FOR SUPPLY OF DRUGS DRESSINGS

ESICGENTRAL RATE CONTRACT NO. - 146(C)

FOR SUPPLY OF DRUGS & DRESSINGS

(VALiD FROM 14th October,2021to 31st October, 20231

RI RY SYSTEMUoTNGN ETc N oGGU ASRDSRERDc D oSEL GRoF AR LES DGU USRD

KI SRERDoDN SSNSU DEUR SGD

R LET ARMG ASE S NICST ES TP DNAVtfeUlttts AND MINERALS

STRICTLY FOR OFFICIAL USE

EMPLOYEES' STATE INSURANCE CORPORATION

ROOM NO.312 & 314, HQRS. OFFICE, PANCHDEEP BHAWAN

C.I.G. ROAD, NEW DELHI_ 110 OO2

702L-2023

ESICGENTRAL RATE CONTRACT NO. - 146(C)

(VALID FROM 14th October,2O2l to 31"t October, 20231

MSY ESTYR AN RNE T UoG

L D RE SoRR lcG D SA LERES FODUR SG UDDR RE SN D oSD SN KUS ESRD GU

R LAAM ETS Gc IS RD S I NET ES TPNANS AND MINERAVITAMI LS

STRICTLY FOR OFFICIAL USE

PUBLISHED BY

DIRECTOR GENERAL

EMPLOYEES' STATE INSURANCE CORPORATION

ROOM NO.312 & 314, HQRS. OFFICE, PANCHDEEP BHAWAN

C.I.G. ROAD, NEW DELHI- 110 OO2

FOR SUPPLY OF DRUGS & DRESSINGS

DRUGS ACTING ON

GE

7021'7a23

PageNo.

Sno. Contents

t-x1 Foruvarding letter along with terms &conditions for operation of Rate GontractNo. 142 (c).

1-3List of Approved Pharmaceutical firms.2

1-17

a

Address withEligible firms

of the3.

1-6lndex

1-34Rate Schedule

I

4.

") ")

5.

STRICTLY FOR OFFICIAL USE ONLY

e.ffirrqqqlfurr(rH Si ivqr{ qzrfi

, qrir qrETr)

EMPLOYEES' STATE INSURANCECORPORATION(Ministry of Labour & Employment, Govt. oflndia)

tqlfi/HEADQUARTERS'q"+dq qqT, *s{rffi qrf, r€ Rd -r ro oozParchdeGp Bh.w.a,C.I.G. Urlg,IIep D6fhl-l 10002

ffi& www.esic.nic.ifl , 8O 1 1 -23234334, dmc-

No.U-zslt2/142C-r

From:

RC 146C)019.1!e lier 202L

1

Further, the following terms & co

Contract:-

Immediately on receipt of this communication, the Chief Direct Demanding Officers(Director/Addl. Director/lt. Director/Dy,.. Director/Administrative Medical Officer/Director(Medical) Delhi & Noida shall intimate the names and complete address of the offlcers who

have been designated as Direct Demanding Officer for the purpose of operation of this

Rate Contract on his behalf, to all the Rate Contract holders. The Rate Contract holders

would entedain the supply orders & related correspondences from the officers working as

DDOS only after the receipt of such communication from the Chief DDOS.

I

The Director Genera!,E.S.I. Corporation,

Panchdeep Bhawan,

C.I.G Road,

NEW DELHI . 110 OO2. .

UNDER THE E.S.I,NO. 146C EFFECTIVE

To

Director (Medical)Delhi/Noida

Dean, PGIMSR'S/ All ESIC Medical Colleges & Hospitals.

l,ledical Superintendent - All ESiC Hospitals,

Director, ESI Scheme - All States/ UTs.

Sub r PURCHASE or DRUGS AND DRESSINGS

Sir / Madam,

Please flnd enclosed,.a copy of DG-ESIC Centralised Rate

supply of drugs and dressings under the Es|Scheme in the country,

CENTRALISED RATE CONTRACT

Contract finalised for

. ts. for a period of two years i,e, w,e.f.

the

Validity of this Rate Contract14.10.2O21 to 31.10.2023.

)at

2. supply orders will be placed by Heads of ESI scheme of various states/ Deans/ Medicalsuperintendents, ESIC Model Hospitals, who for the purpose of this Rate contract, shall bedesignated as Chief Direct Demanding Officer and will exercise the powers of DirectorGeneral, EsI corporation in all matters connected with the execution of supplies and I orwherever specifically provided in the terms & conditions of the Rate contract. The chiefDirect Demanding Officer can also designate any of his subordinate officer as DirectDemanding Officer (DDO) to operate this Rate Contract.

3 All the supply orders shall be signed only by the officers who have been duly authorisedand included in the,.list of DDOs;.. DDOs will:.send seanned cqpy of the purchaseorder through email follgwed'by spe-ed post directli to thb firm.,,i i:

The Chief DDOS may bring to the notice of the undersigned the discrepancies (especially in

rate, packing, composition of the drug) if any observed by them.

4

5. The Chief DDOs shall monitor the holding firms in regardto their execution of supply ord ted quarterly non-supply report along with

specified by the Direct Demandi

6

9. No guarantee can be given as

ng Offlcers. ..:.i

. .:i

to the minirnum quantity will be drawn against this

.....

wniihcontract but the pharmaceutical firm will supply quantity as may be ordered by the Direct

Demanding Officers during the currenry of the contract

10. Supply orders against the contract will be accepted as long as these reach thePharmaceutical firm on or before last date of the currency of the contract. Supply orders

received during the closing days should be complied within due course, in accordance withthe contract if even though in some cases owing to contract having expired, supplies are

to be complied with even after the expiry of the last date of the contract.

R.C.

No.

Drug

Item No. &Name of

- Qty. notsupplied

Remarks

4. 5 8.

II

Name offirm

S.O. No..r rwith

Date

RiskPurchase/

penaltylevied

Paymentif

pending

1. 2. 3. 6. 7.

under this

lowest rates.

While taking this step, the benefit of concession in.rate of GST GST Act or

the rules framed there under will be taken into account.

7. It will be Director Demanding Officer that necessary

funds are be €rranged expeditiously within 4-6 weeks

time of the execution of the orders-b}Jhe Rate.eontract Holder and there should not be

unnecessary delay in the payment of their bills,

8. Supply orders will be placed from time to time during the currenry of the contract in which

the exact quantities required on each occasion together with the date of delivery shall be

ensured before placing order by theavailable and payment of bills should

11. Notwithstanding any omission or shortcoming in the supply order it is incumbent upon thePharmaceutical firm to supply the item as per the specifications of the relevant ratecontract.

SUPPLIES

12. The purchaser will not pay separately for transit insurance and the contractor will beresponsible for delivery of items covered by the supply order in good condition at thespecified destination and for this purpose freigh! insurance, Octroi etc, if any, will have tobe borne by the supplier, The consignee wiil, as soon-as possiblqibut,fiol,later.than 30days of the date oi.arrival,of stores at destination, notiil, tird cirirtredor irf any loss ordamage to the store$, that may have occurred during the transi*' , r I ..

I13. During transit pharmaceutical firm should maintain

rsethe recommendedif on checking at is

L4.

t7.

inst the said orderq-n-suPPlY.

of GST exceptrding.

without such stamping will not be considercd valid and will be rejected.

b) Loose supplies/damaged packing/tempered or damaged labeled supplies shall not be

accepted under any circumstances:1

c) Supplies to be made in proper. boxes-..

d) Liquid orals to be supplied only in glass/ plastic bottles conforming to Drugs &Cosmetics Act and rules made there under.

III

are

15. In all contracts for items/ drugs,- which are branded with 'ESI SUPPLyT:tnark includingrejected items/ drugs, it would be a. condition that such,items/ drugg,fjll: notrbe sold to thepublic/open market.

16. Marking:

e) Large volume parenterals to be quoted and supplied only in plastic bottles / polypacks

conforming to Drugs & Cosmetics Act and rules made there under.

f) It should be ensured that only first use packaging material of uniform sizeincluding Bottles and vials should be used for making supplies on the basis of ESI

Rate Contract.

i) All containers i.e. bottles, tins, cartons, tubes etc., are required to be secured withpilfer-proof seals to ensure genuineness of the products packed and the correctness of

the contents. MRP should not be written on any labels otherwise it will disqualified.

b)

Imported Drugs: As on the date of delivery, Drugs should have a minimum

50% of valid shelf life from the date of manufacture.c)

not be anv loss tothe CorPoration'

19. Pharmacoooeia Soecifications :

pharmacopoeia specification IP/BP/USP etc. should be clearly mentioned against each

drug/constituent of the formulation supplied as per the provisions of Drug and Cosmetics

Act.

'o'lHf :'#',i:"J,1*'#ffi'ffi Iffi.H#?XHfr ffi :6q,'ffi :,'Hi:...H,t;1iorder. '-i, "'f { *-'oU $ "

*1

IV

18' Life-Eriod:a) For Drugs having shelf life of Two years or less: As on the date of delivery,

Drugs should not be older than one fourth (1/4) of its shelf life from the date of

manufacture.

For Drugs having shelf life more than Two years: As on the date of delivery,

Drugs should not be older than one sixth (1/6) of its shelf life from the date of

manufacture.

9) All primary packing containers should be strictly conforming to the specifications

described/ mentioned in the relevant pharmacopoeia.

h) Packing should be able to prevent damage or deterioration during transit.

-f-- rl

21. It should be ensured that ISI code No. is indicated on the packing and at the time of

supplies, it must be ensured that the items supplied has ISI Mark as well as Code No',

as is the statutory requirement of the Bureau of Indian Standards.

Approved Rate Contract Holder should submit a Test Report that paticular

batch of medicines tested by the Governmenv Government approved

Laboratories (as per list circulated from ESIC Hqrs/ Hospitals/ State Govt. from

time to time) along with each supply.

The Director General, ESI Corporation shall be at liberty to undertake regular

and random testing of the drugs supplied by the pharmaceutical firm/ firm at

regular interval to maintain and ensure the quality of drugs:

The Chief D.D.Os may get at least l0o/o of the drugs tested in the Government

Laboratory, or in any of the Govt, Approved laboratories. Instructions issued in

this regard from Hqrs. Office time to time may please be adhered to'

Details of the items found not of standard quality should be brought to the

notice of the undersigned along with the test reports immediately. All such test

reports should necessarily come through Chief D.D.Os only. A copy of the test

report should be sent immediately to the firm, the concemed Drug controllers,

and respective Central Drug Control authorities for necessary action'

b

a

f

c

d

The report of the Govt./Govt. approved laboratory shall be accepted by the

pharmaceutical firm. In case the same is disputed by the pharmaceutical firm

the report of the Appellate Laboratory only will be accepted as final'

However the same should be submitted within three months, from the date of

communication of the disputed test report to the pharmaceutical firm. For this,

the pharmaceutical firm should approach the concerned Drug Control

Authorities for getting the drugs tested, as per procedure, from the Appellate

h

Laboratory.

at the time of supplY

If any drugs supplied against this Rate Contract are found to be not of

standird qullity on inspection by Competent Authority, the pharmaceutical firm

will be liable io replace the entire quantity within 15 days otherwise risk

purchase will be charged from the Pharmaceutical firms..

If the product is found to be 'not of standard quality', the cost of testing will be

recovered from the suPPlier.

If standard quality is not maintained in two batches an two years

duration of the rate contract, the drug of the that company will be

blacklisted and debarred from running in ESIC rate contract for a

oeriod of three vears.

22. Testing of Druos - Qualitv Control

s.

AEOB

m2

The classification of defects into different categories is as per theguidelines issued by the Druo Controller of India & action will be takenbv ESIC for each categorv of defects, described as under:-

A. CATEGORY'A'DEFECT (Spurious / Adulterated Drugs)-If any item / Batch of the item declared Not of Standard quality (NSQ) underCategory A.. Recall of the NSQ item immediately from all ESIC/ ESIS User Units. Recoveries to

be initiated by the DDO's wherever payment had been made alreaQy.

. Forfeiture of Pitormarlce€eiurity fromthd'respeftive D.GEgI--C- Rate lontract for all

the quoted drugs.

. Debarring of the Rate Contract holder / Pharmaceutical firm from current and all

future DGESIC Rate Contract for a period of five (5) years.

Rate Contract Holder/ Pharmaceuti

compensation (if any) !o in of item

declared NSQ and in case of a during

administration of the drug.

to be initiated by the DDOt wherever payment had been made already.

. Fofeiture of Performance Security from the respective DGESIC Rate Contract

for all the quoted drugs.

. Rate Contract Holdbl Phirryaceuticallirm -will be debqfed'f6! further supply of

the said NSQ item.in the crjirency of-the Rite'contrac[''

r Debarring of Rate Contract Holder/ Pharmaceutical flrm immediately from

current and all future DGESIC Rate Contracts for a period of three years.

. Rate Contract Holder/ Pharmaceutical firm will be liable to pay damages/

compensation (if any) to individual/ individuals arising due to consumption of

item declared NSQ and in case of any adverse reaction reported in the Hospital

during administration of the drugs.

VI

23.

B. CATEGORY'B' DEFECT (Grossly Substandard Drugs)

I. If single item/.Batch of item is declared NSQ under Categoty B. Recall of the NSQ item immediately from all ESIC/ ESIS User Units. Recoveries

II. If

I

C CATEGORY' C' DEFECT (Minor Defects)

II

If single item/ Batch of item is declared NSQ under Category C

. Recall of the NSQ item immediately from all ESIC/ ESIS User Units. Recoveries

to be initiated by the DDOt wherever payment had been made already'

. Forfeiture of Performance Securlty from the respective DGESIC Rate Contract

for that drug.

. Rate Contract Holder/ Pharmaceutical firm will be debarred for further supply of

the said NSQ item in the currency of the Rate contract.





If more than one item/ Batch of item belonging to any individual

pharmaceutical firm is declared NSQ under CategolY C within a year

. Recall of the NSQ item immediately from all ESIC/ ESIS User Units. Recoveries

to be initiated by the DDO's wherever payment had been made already.

. Forfeiture of Performance Security from the respective DGESIC Rate Contract

for all the quoted drugs.

. Rate Contract Holder/ Pharmaceutical firm will be debarred for further supply of

the said NSQ item in the currency of the Rate contract.

. Debarring of Rate contract Holder/ Pharmaceutical firm immediately from

current and all future DGESIC Rate Contracts for a period of three years





Deliverv Period - Risk Purchase

a. Deli".,-y period will be of six week from the date of issuing of the P'O' sent

by email and the Pharmaceutical firm shall execute the order within stipulated

time.

b. If the pharmaceutical firm fails to execute the supply order within the-

stipulated period of six weeks, a penalty of two (2) per cent of the value of

the order calculated at the contract rate per week or a pat of a week will be

levied. The maximum penalty for late supply shall not exceed 10o/o of the

total value of the ordei/orders. A pharmaceutical firm can seek extension of

the delivery period with the prioi consent of the Director Demanding Officers,

if it is no[ in a position to execute the order in time' Such extension is

permissible for a maximum period of 5 weeks only but penalty will be levied'

24.

VII

c In case of failure to supply, the Corporation reserues the right to purchase

the stock from other sources as risk purchase, i.e. purchase from any otherpharmaceutical firm or firms, in the rate contract or from outside the contractat the discretion of the Direct Demanding Officer concerned at a competitiverate or from local chemist.

That extension of deliveru oeriod cannot be claimed as a matter ofriaht but will be at the discrction of concerned Officer.

if the itemsl.drugs are not supplied by the sche(0le date (as indicated aboveor by the eltended date) full or in paft, the order in respect of the quantitynot supplied is liable to' be cancelled at the risk and expense ofpharmaceutical firm. The extra expenditure involved in procuring supplies

from elsewhere i.e. Local Pu /other running Govt. Contract etc.,in that case, will be recove rmaceutical flrm, in full atdiscretion of Dire s thus due will be

cer or which atany time the or any other

He will be

e powers of Director ration incase cy arises. Apat from on, thebidde linviteother Rate

r a perl

d

e.

rsw

i

25. Quoting of Price

I firm reentry

the nextiting of

in the schedule

other charges.a. The price must be q

annexed and should

b. GST, if extra, where legally leviable and intended to be claimed, should be

distinctly shown separ_ately,alongwjth the plice qyote{, Wllg-e this is not done,

no claim of GSTrwilft'd(mi@d at dli*laGistdle and on any ground

whatsoever.

VIII

deducted from any sum payable by the Direct

26. Pavment

Payment for the supply will be made within 4 to 6 weeks (after receipt and

acceptance of the drugs/items) directly by the Direct Demanding Officers orthrough nominees to whom bills are submitted. Notwithstanding any omission orshortcoming in the supply order it is incumbent upon the pharmaceutical

firm/bidder to supply the items as per the specifications of the relevant ratecontract. No claim for the payment from contractor shall be entertained after thelapse of thr

Any dues

ee yea.rs'of arising of the.claim. li .l

or payments that have arisen to the ti6n,.,from the27.

28.

29.

pharmaceutical firm for which no specific time limit has been id down in the

terms and conditions shall be payable by the pharmaceutical firm within such time

limit as may be prescribed in the letters/orders addressed to the pharmaceutical

firms.

No other docu

supply orders.

ment should be entertained for giving any cognizance for placing the

Acceptance letter issued to the firms by this office cannot be used for placing

orders.

SCoGeM, under Ministiy of Labourl& employnilnt has" grarited exemption to

operate DGSIC Rate Contract for drugs and dressings as per Minutes of the

meeting vide Office Memorandum no. 2-2002512512017-Adn II dated 29.01.202L.

IX

Any payments that have been demanded as per the provisions of above

mentioned clause or under any other clause shall be payable within the time laid

down. On failuie to do so:. -. 'i - r'

. The pharmaceutical firm shall be liable to be debarred for supplying items/

drugs etc. to the Corporation for a period not exceeding three years.

. The Corporation reserves its right to take appropriate legal action against the

defaulting firms as may be Iegally advised, including claim for compensation

and damages for the period of delay and / or simple interest 10o/o per annum

for each day of default.

Rate Schedule along with Iist.of item-wise flnalized rates, along with name of the

approved firms is enclosed. In regard to items where rates.'of more than one flrm

have been approved, order should be placed to the firm at First Preference and

whose rates are the lowest. In case of non-supply by such firm, order shall be

placed to the firm with the next higher approved rate invoking risk purchase.

30.

31.

32.

Yours fai fully,

Encl.: As above.

Dy. Medical Com issioner(RC)FOT: DIRECTOR GENERAL

All Chief Direct Demanding Officers (ln-Charge) of ESI Scheme of all States/UT's for

information and with the request to circulate this letter along with enclosures among

all DDOs under their control for necessary compliance. They are also requested to

send the list of DDOs to the firms approved in the Rate Contract,

PPS/PS to Director General for information of Director General.

PPS/PS to Financial Commissioner for information.

PPS/PS to Medical Commissloner(Procuremenv Medical Services/ Medical Education /Medical Administration) for information.

Accounts Branch - V (Hqrs. Office)

Dy. Medical Commissioner (RC)

FOT: DIRECTOR GENERAL

Copy to:

1

2

3

4

5

x

33. Force Majeure:

If at any time during the applicability of Contract the bidder fails to discharge its

Obligation due to force majeure (natural disaster or act of God etc.) he will

promptly notify the Director General or its representative about the happening of

such an event. The Director General or its representative is solely entitled to

terminate/ determine the order/contract in respect of such performance of the

bidde(s) obligations if he so desires. The obligations under the contract on behalf

of bidder for the contract shall be resumed as soon as practicable after the event

has come to an end or ceased to exist.

34. It shall be the sole responsibility of Dean/MS/ DIMS/ Head ofInstitutions of respective field unlts to maintain an optimum Inventorylevel with strict contro! as per ABC-VED matrix and ensure the drugformulary of the respective institution is followed in right earnest toprovide medical services to ESI beneficiaries.

This issue with the approval of Competent Authority.

tr,

I J

Approved Vendor List 146C

SNo. Name of the Firm

Pharma Limited1

Aristo Pharmaceuticals h/t. Ltd.2

Bal Pharma Limited3

Bharat Serums And Vaccines Limited4

Biodeal LtdPvt.S5

La boratories Private Limited6

Ci la Limited7tI

8

East India Pha9

!

Emcure Pharmace10

LimIndla Private Lim11

Goa Limitedo Known As Belladona Plasters Limt2

2023Franco- Indian Pha13

Franco-Indian Remedies h/t Ltd14

& Dohme CoOf Merck ShaFulfordUsa

ndia Limited A Subsidia15

Gal ha Laboratori es Limited1b

Gennova armaceutica ls Ltd.17

Glaxo Smithkl ine Pharmaceuticals Ltd18

Page 1 of 3

t T

T1

Ei!) nv


Name of the FirmSNo.

Goldw in Medicare Ltd.19

Hab Pharmaceuticals & Research Ltdz0

Hind ustan Laboratories Limited2l

Indoco Remedies Ltd22

Intas Pha rmaceuticals Ltd73

lations tut. LtdCa24

ndiaLark Laboratories25I I

Limited)A

Maan Pha27

Macleods Pha28

Medifo rce Healthcare P29

Micron Pharmaceuticals30

rmaceuticals h , Ltd, 20 3Midas Care Pha31

Prlvate LimitedModi Mundi32

Overseas Healthcare h Ltd33

Panacea Biotec Pharma Limited34

Pfizer Limited35

Pfizer Product India Private Ltd36

Page 2 of 3

?.

.$!ll

;i

Ela

I


Name of the FirmSNo.

rmerel Known As Merck LimProcter & Gamble Health Limited37

India Limited38

Pulse Pha rmaceutica I ht Ltd39

Sai Parenterals h . Ltd.40

nature ica I4l

LimitedTablets42

Themis Medica re Limited43I

U nimarck Pharma44

USV Private45

Virchow Biotech46

aVivimed Labs Ltd.47

Wallace Pha rmaceutica ls tut. Ltd.48

2A2L-2023Wockha rdt Ltd.49

h . Ltd.Zenith D50

Zim Laboratories Limited51

Page 3 of 3

H

t

h.

$ar,4

I

Mobile/ Tel No: 9821838599 /022 66061202166061221

Fax No (if any)r 022 66061200

Email: [email protected]

Vendor NameAJANTA PHARMA LIMITED

Ajanta House, 98/Govt. Industrial

Estate, Charkop, Kandivali (West),

Mumbai - 400 067

Vendor Name

ARISTO PHAPRIVATE LIMITED

29, DLF Industrial

New Delhi-1100

Vendor NameBAL PTIARMA LII'IITED

5th Floor, Lakhmi Narayan

Complex, 10/1, Palace Road,

Bangalore-560052

168 IMobile/ Tel No: 9480811

080-4t379527

Fax No (if any): 080-22354057


[email protected]

[email protected]

Term 1 Delivery within 6(six) weeks (of the actual date

of dispatch) of supply order on FOR Destination

basis

Term 2 GST as applicable will be extra except for items

where no tax has been approved.

Term 3

ctrIf at any time documents submitted/information given by the firm in the tender is

found to be false/ erroneous, the award will be

cancelled.

lrm 4

(of the actual date

r on FOR Destination

pt for itemsxtra exce

lroved.

s

Iftender is

rd will be

submitted/

Term 1

order on FOR Destination

(of the actual date

Term 2

T*

GST as applicable will be extra except for items


u to

IfI

neous, the award will beerro

cancelled.

firm in the tender is

documents submitted/

Term 4 Supply to be made directly.

Page 1of 17

Mobile/ Tel No: 9818670171 /017-2s976403104

Fax No (if any):Email: [email protected]

] Supply to be made directly.

Term 1

Term 2

Term 3by the

found to be false/

cancelled.

erroneous,

Term 4

vendor l{ameBharat Serums and vaccinesLimited

Mobile/ Tel No: 9910025803 /022-45043476

Fax No (if any): 022-45043200

Email:[email protected]

sandeep.shinde@bharatserums com

institution@bharatserums com

[email protected]

[email protected]

Vendor NameBIODEAL PHARMACEUTICALS

PvT LTD,

770-712, 7th Floor, Jasola District

Centre, New Delhi - 110025

Mobile/ T el Not 7 42874422L I011-46106868

Fax No (if any): 011-46106868

Email! [email protected]

Vendor NameCheryl Laboratories PrivateLimited

Plot No. 434, A Wing, Ground Flo6r,

Parsian Apartment, V P Road,

Andheri West, Mumbai - 400 058.

Mobile/ Tel No: 9819800108 ioz2 - 42s5 49 t8 I 99202229s8

Term 2

Term 1 Delivery within 6(six) week (of the actual date


basis

Term 2 GST as applicable will be extra o(cept for items


Term 3 If at any time documents submitted/

information given by the firm in the tender is

found tocancelled

be false/ erroneous, the award will be

Terin 4

Term 1 Del ivery with n weeks (of the actua I date


basis


where no tax has been a roved




cancelled.


Term 1 Delivery within 6(six) weeks (of the actuaI date


basis

GSTa pplicable will be extra except for items


If at any time documents submitted/

lnformation given by the firm in the tender is


cancelled.

Term 4 Supply to be made directlY.

Page 2 of 17

3rd Floor, Liberty Tower, Behind

Reliable Plaza, Airoli, Navi Mumbai -

400708

A

J

Fax No (if any): 022-26715899


a

supillto be madAdirectly. rt'

IIa

a

a )n1Term 3

Vendor Name

CIPI.A LIMITED

Cipla House Peninsula Business

Park, Ganpatrao Kadam Marg, lower

Parel, Mumbai- 400 013

Mobile/ Tel No: 9820273567 /8874450173 I022 24826000

Fax No (if any): 022 748?6120


[email protected]

Vishwas,[email protected]

Vendor Name

ConceptLimited

Fax No (if any)rEmail: sanlay.

[email protected]

Vendor NameEAST INDIA PHARMACEUTICAL

WORKS LIMITED

E-156, 1st Floor Kalkaji, New Delhi-

110019

Mobile/ Tel No: 9871231000 /o 1 | -4287 847 4, 4287 8458

Fax No (if any): 0It-42878474

Email: eipwl-delhi@eastindiapharma org

[email protected]

20

Delivery within 6(six) weeks (of the

of dispatch) of suPPlY order on FOR

actual date

Destination

basis

Term 1

Term 2 GST as applicable will be extra except

where no tax has been aPProved.

for items

If at any time documents

information given bY the firm in

submitted/the tender is

award will be

ca

be

Term 3

(of the actual date

FOR Destinatlon

for itemstra except

oved.


award will be

Delivery within 6(six)

of dispatch) of suPP|Y

week (of the actual date


023Term 1

LGST as applicable will be extra except for items

no tax has been awhereTerm 2


award will be


information given bY the Rrm in

found to be false/ erroneous, the

cancelled.

Term 3

Supply to be made direcUy.Term 4

Page 3 of 17

801, Hubtown Solaris (entrance

From B Wing) N S Phadke Marg, Off

Teli Galli, Near Andheri FlYover,

Andheri (East), Mumbai-400069

Mobile/ Tel No: 9891249600 /022- 42418888

Term 1

nta

weeks6(six)Delivery

basis

tax has

GST

nowhere beenTerm 2

information given

found to be false/

anythe

erroneous,

timeattf documentsinfirmby

lerm J

Term 4

basis

Survey No. 255/2, Phase I, Rajiv

Gandhi IT Park, MIDC, Hinjawadi,

Pune - 411057

Mobile/ Tel No: 9370130072,

9830890292 /020 39821000

Fax No (if anY): 020 39821020


niladri,[email protected] in

vendor Name

Emcur€ PharmaceuticalsLimited

Vendor Name

Essity India

Fax No (if any):Email: ravinder.ah

[email protected]

sonal.kakadia@essity com

GOA -403409

Mobile/ Tel No: 98111 09333 /0832-2324500 I 998778 3 3 1 1

Fax No (if anY):


[email protected]

[email protected]

Vendor Name

Essity Operations Goa Limited(FormerelY known as Belladona

Plasters timited)

NIR,ANCAL ROAD, CURTI 'ffi*



week (of the actual date


basis

Term 1

GST as applicable will be extra exce


pt for itemsTerm 2

onn

If at anY timen the tender is

award will be

documents submitted/Term 3

disuperm

(of the actual date

for items

3 submitted/tender is

will be

If at

(of the actual date

on FOR Destination

basis

6(six) weeks

supply orderofd )spatch

be extra except for items

no tax has been awhere7

information

found to be

cancelled.


award will be

documentstimeafI at nynfl rmn theive bys

theerroneous,lse/

Supply to be made directly.Term 4

Page 4 of 17

E - 902, Lotus CorPorate Park,

Goregaon (East), Mumbai-400053

Mobile/ Tel No: 9811109333 /022-61554300

.!ft

basis

week56(six)FOR Destination

as applicable willGSTTerm 2

documentstimeTerm anyin thefirmthebygiveninformation

awardtheerroneouttofound

Fi

directly,be made

aaa

within1Term Delivery

GSt

Term 3

vendor NameFranco- Indian PharmaceuticalsPvt. LU.

20,DR,E.MOSES ROAD,

MAHALAXMI, MUMBAI.4OOO 1 1

Mobile/ Tel Nor 9970810085 i022-23084061


f [email protected]

Vendor NameFRANCO.INDIAN REMEDIES ''. -

PvT. LTD

Mobile/ Tel No: ,997 08s /022-23084061

Vendor NameFulford (India) Limited (A

subsidiary of Merck SharP &

Dohme Corp, USA)

Kurla Complex, Bandra (E),

400098.

Mobile/ Tel No: 9958445856 i022-67898888/98 10288687

Fax No (if anY):Email: [email protected]

[email protected]

[email protected]

8th Floor, Platina Building, Next to...,. ..

CITI Bank, C-59, Block -G, Bandra' '

Delivery within 6(six) weeks (of the actual date


basis

GST as applicable will be extra except fior items

where no tax has been a rovedTerm 2

Term 3 If at any time documents subm


se/-.,e rda I beAWerron thbe eouSn Ld

nca

itted/

erm



basis

Term 1

Term 3

Term 4

th n 6(six) weeks

u pply order on FOR Desti natl on

Term z GSl. as appliqAble will be extra except for items

whriie no tai hds been approved.



found to be false/ erroneousr the award will be

cancelled

Term 4

Page 5 of 17

Fax No (if any):

20,DR.E.IVIOSES ROAD,

N4AHALAXIYI, MUMBAI - 11OOO1 1

Email: mkapse@franmlndiari'com

Term 1

tlalt

GSTTerm 2

If at time documents submitted/anyby the firm in the tender isinformation given

found to be false/

cancelled,

erroneouq the award will be

Supply to

(of the actual dateTerm 1

Term 3

Supply to be made directly.

E-221,KANAKIA ZILLION ]UNCNON

OF LBS&CST ROAD,BKC

ANNEXE,KURLA WEST,MUMBAI+OO

070

Mobile/ Tel No: 7718883168 /022 - 2654 4999 / 3010 0999

Fax No (if any): 022 - 2654 4900 I3040 0900


[email protected]

[email protected]

Vendor NameGennova Biophar

Survey No. 255/2,iPhag*.L Ra

Gandhi IT Park, MIDC, Hinja

Pune - 411057 :.:

wadi;.

_ ::'Mobile/ ra no: gjzofloolz;9970009897 I 98308902921

020 3982 1000/ 7 4287 14333

Fax No (if any): 020 39821020

Email: anil.arora@emcure,in

nitind@emcure,co,in

[email protected]

GSK House, 252, Dr. Annie BeiantRoad, Worli, Mumbai-400030

Fax No (ifany)r 022-24959494


[email protected]



basis


where no tax has been approved,

If at any time documents submitted/informFtion giveo,-by the firm jn the tender is

found to !g fals€l €rroneous, the award will be

cancelled.

Terin c suppi!; tb be madi: directly. .

Term 1

2rm GST as applicable willwhere no tax has been a

except for items

Term 3 If at any time documents submitted/information given by the firm in the tender is

found to be falsel erroneousr the award will be

cancelled.



basis

Term 2 GST ai:applicable,will be extra except for items


Term 3 If at any time documents submitted/information given by the firm ln the tender is

found to be false/ erroneous, the award wlll be

cancelled.


Vendor NameGALPHA I.ABORATORIES

LIMITED

Vendor NameGlaxo SmithklinePharmaceuticals Ltd

Mobile/ Tel No: 9167336119 /022-24959766

k

Term 3

Delivery within 6(six) week (of the actual date


basis

Term 4 ,Supply to be-made directly.

Page 6 of u

vendor NameGoldwin Medicare Ltd,

10U 102, A Wing, Vailankanni

Towers, off Senapati Bapat Marg,

Mari Nagar, Mahim(W) Mumbai -

400016.

Mobile/ Tel No: 8928.387012 /022-2445 91161718

89283870 1 1/ 9324203479

Fax No (if any): 022-2445 glLg

Email: alves@alvesgroup,com

sales@alvesgroup,com

Vendor NameHAB PHARMACEUTICAL &RESEARCH LTD

308 3rd Floor T.v Industrial Estate

S. K Ahire lvlarg Worli Mumbai 30

022-66267409

Fax No (if any): 022-66261414


Vendor NameHINDUSTAN LABORATORIES

LIMITED

A-302, Victory Park, Chandavarkar

Road, Borivali (West), Mumbai -

400092, Maharahstra

Mobile/ Tel No: 7710055194 /022- 424 60500, 42460526 I9820787558

Fax No (af any)= 022-42460531

Emai} tenderG:hindlab.com

[email protected]



basis



Term 3

Term 4

If at any

inforry,liltion gi

found:to be fa

cancelled,:

time documents

ve!l-byeous,

firmr..l n

tiiea


award will be

Supply t6 be made di v.

Term 1

Term 2 except for items

has been approved,G ll be extra

where

by the firm in the tender ls

time

canc

ents

informatiotfid award will be

submitted/lf .at an

Term 1 Delivery withii 6(six) week (of the actual date

6tdisDatch) of supply order on FOR Destination

basis

GSTra{af$litab,le'wil be extra except for items

where ho hx ttits b€€h approved.




cancelled.

Term 4 Supply to be made direcdy.

Page 7 of L7

Mobile/ Tel No: 9930212908 /

Term 1


of dispatch) of supply order: on FOR Destination

basis

Term 3

Term 4 Supply to be

Teim 2

Vendor NameINDOCO REMEDIES LIMTTED

Indoco House, 166, C.S.T. Road,

Santacruz (East), Mumbai - 400 098.

Mobile/ Tel No: 9004046733 /022 - 6287 1000 / 6817 1250

Fax No (if any): 022 - 2652 0884


Vendor NameINTAS PHARMAC

LIMITED

t-

Corporate House,

S.G. Highway, Tha

380054

Mobile/ Tel N079-39837000

Fax No (if any):Email: ketan-shah

Vendor Name

Jyoti Capsulations hrt'Ltd.

123/37 Saresh Bagh, Kanpur Uttar

Pradesh 208012

Fax No (if anY):


Mobile/ Tel No: 919956335559 /9 1 9956335559/ 97 92999909



basis

Term 1


where no tax has been a

Term 2




Term 3

up toferm 4

) week (of the actual date

on FOR Destination

Term except for itemsGST as app

tender is

rd will be

submitted/

information gIf

ade directly.


(of the actual date

Term 2 GST as applicable will be extra except

no tax has been a

for items

where

Supply to be made directly'Term 4

Page 8 of 17

l)

3

cancelled. - * ,&tao€

Term ,l


I Term 3

Term 4

time documents

by

be erroneous,

Delivery within 6(six) weeksTerm l

documents submitted/flrm in the tender is

the award will be

A-lo5l2, Okhla Industrial Area,

Phase-II, New Delhi-110020

Mobile/ Tel No: 9811023731 /ott-40717777

tr€ iflFax No (if any)3 el@t}tf&*"Email: [email protected]

hrklab(Dgmall.com

Vendor NameLUPIN LIMITED

Mobile/ Tel(022) 66402969

Fax No (if any):Email: manoisin

PLOT NO.1, G.I.D.C. PHASE-z,

MODHERA ROAD, MEHSANA-384

oo2

Mobile/ Tel No: 9825070124 /02762 - Z24UZ

Fax No (if any): 02762 224610


Delivery within 6(six) weeks (of the actua


basis

ldateTerm 1

GST as applicable will be extra except


for items

rovedlerm 2


information given by the firm insubmitted/

the tender is

award will be

ca

be

Term 3

(of the actual date

on FOR Destination

Term 2 GST as appli for items

eTm 3

n

If at submitted/tender is

rd will be

order on FOR Destinationweeks (of the actual date


n approved.


the firm in the tender is


me

cancelled.


Page 9 of 17

Vendor NameL/ARK LABORATORIES (INDIA)LTD.

3rd Floor, Kalapatru InsPire, Off W.

E Highway, Santacruz ( E) Mumbai

400055

Vendor NameMAAN PHARMACEUTICATS LTD

,

) tTerm 4 I

Term 1

basis

has been approved.

any timegiven by

found to be false/ erroneous,

Term 4

\Yt;

within 6(six)Delivery

basis

1Term

a

Term 2

l4

Term 3t-I

Mobile/ Tel No: 8657553U7 /22667 6267 2 I 9867868002 i

Fax No (if any): 2229256599

Vendor NameMACLEODS PHARMACEUTICAISLIMITED

Atlanta Arcade, Marol Church Road,

Opposite Leela Hotel , Andheri

(East), Mumbai - 400059


Vendor NameMEDIFORCE HEAL

PRIVATE LTD

A-25, Defence

Road, Meerut UP

Vendor NameMICRON PHARMACEUTICALS

Plot no 2117 A-2 Phase III GIDC

s0 IMobile/ Tel No: 99241707

0260 240s400/ osl06l07

Fax No (if any): 0260 2405419


sales@micronpharma,in



basis



Term 3 If at any time documents submitted/n on n the tender is

US, award will be


(of the actual date

on FOR Destination

Term 3 If at any submitted/tender is

rd will be

Term 1 week (of the actual date



where no tax has been approved.Term 2

Term 3a

erroneous, the award will be

Ifi firm in the tender is

cancelled.



Page 10 of u

Mobile/ Tel Not 9717737367 I0 t7 0 -4255 t37 I 9820081388

Fax No (if any): 0170-4255137


Vapi 396 195 a

Term 1


where no tax has been aDDroved.

Term 4 Supply to be made direcdy.

Vendor NameMIDAS CARE

PHARMACEUTICAIS PvT. LTD

Lotus Corporate Parlg B Wing, 3rd

Floor, Jay Coach, Graham Fifth

Compound, WE Highway, Goregaon

(East), Mumbai 400063

Mobile/ Tel No: 98

02242193900

67478376 I

Fax No (if anY):Email: [email protected]

[email protected]

Vendor NameMODI MUN

LIMITED

1400, MODI

PLACE, NEW D

Mobile/ Tel I{o:011-4250 4555, 0

Fax No (if any): 01

Email! pmd@modimun

arvindmadan@modimund

Vendor NameOVERSEAS HEALTH CARE PVT.

LTD,

335Km Milestone, National

No.1, P.O. Box 25, Phillaur,

Jalandhar, Punjab State

Mobile/ Tel No: 9872019733 /01826-222886

Fax No (if anY): 01826-222885


[email protected]



basis


where no tax has been aPProved.Term 2


award will befi rm

a

nd

Term 3

Term 4

,rsfl

Supply to be made directY.

of the actual date

FOR Destination


taDDroved,GST ASerm 2

locuments submitted/

re firm in the tender is

reous, the award will be

:ctly.

Delivery within 6(six) weeks


basis

(of the actual dateTerm 1

extra except for items

approved.

If at any time documents su



bmitted/

cancelled.

Supply to be made directlY.Term 4

Page u of 17

aI

oo

of dispatch) of suPPIY order on

weeks6(six)Delivery within

basis

Term 3

Term 4

an-r -l'! tl2Term

Term 3

Vendor NamePANACEA BIOTEC PHARMA

LIMITED

B-1 Extn,/A-27, Mohan co-ope rative

Industrial Estate, Mathura Road,

New Delhi - 170044

Mobite/ Tel No: 9310103950,

9560709313 /98101011-41678000

Fax No (if any): 01 1 CEmailr ka

[email protected]

[email protected]

Vendor NamePFIZER LIMITED

The Gpital 1802/1

70, G-Block, Band

Bandra (E)

Fax No (if any):Email:GOVERNMENTTEN

Rajesh.kadian2@Pfizer

Satendra,seth@Pfi zer.com

Vendor NamePFIZER PROCUCTS INDIA PvT

LTD

The Capital 1802/1901, Plot

70, G-Blocl! Bandra Kurla

Bandra (E) Mumbai - 40005

Mobile/ Tel No: 9771414156 /2266932000

Fax No (if any)! 2226540274

Email:GOVERNMENTTTNDERSPPIPL@pfi zer.com

[email protected]

Term 1 Delivery within 6(six) week (of the actuaI date


basis


where no tax has been aPProved'

Term 3

D(If at any time documenE submitted/


found tocancelled

be award will be

Term 4 sup

(of the actual date

FOR Destination

pt for itemsextra exce

proved.lerm z GST as

tender is

rd will be

submitted/

tly.

in 6(six) week (of the actua

of dispatch) of suPPlY order on FOR

basis

I date

Destination

be extra except for itemse

approved.

at any time documents



submitted/If

cancelled.

Term 3

Supply to be made directlY'Term 4

Mobile/ Tel No: 97714i4156 /2266932000

f

t

I

TermI

Delivery within 6(six) weeks

of dispatch) of supply order on

Term 3 If at any time

information given bY

found to be ialse/ erroneous, the

Supbly to made,-tt

r

Term 1

2 GS

Page 12 of 17

iflIl"H:,ffS56

Satendra.seth@Pf izer,com

Vendor NameProcter & Gamble Health

Limited (Formerely known as

Merck Limited)

Godrej One, 8th floor, Pirojshah

Nagar, Eastern ExPress HighwaY,

+91 22 6866 9000

Fax No (if anY): +91 22 6866

9800


Vendor NamePSYC

LIMITED

Plot No. 17,

Faridabad-12100

Mobile/ Tel No:

or29-2282691

Fax No (if anY): 012

Email: kapoorsatish

Vendor Name

PUISE PHARMACEUTICAL PvT

LTD


9311083087 /91-40-23119992

Fax No (if anY): 91-40-23119992

Emaill [email protected]

[email protected]

Plot No: 18/1, Sector III, ,,iG faETechno Enclave, Hitech CitY&*- iltHyderabad - 500 081'

t



weeks (of the actual date


basis

Term 1

GST as applicable will be extra except


for itemsTerm 2


award will befirm

cancelled.

finfo

beu

Term 4 Supply to be made directlY'

the actual date

R Destination

for items


award will be

tlv.

six) weeks (of the actual date

pply order on FOR Destination

basis

) of su


approved.

information

found to be

cancelled.

mb ittedus IdocumentstimeaatfI nyr istendefi rm thenthebygivenberdawathefa se/

Term 3

Supply to be made direcdY.Term 4

Page 13 of 17

basis

of dispatch)

weeks6(six)

of supply order onTerm 1

Supply toTerm 4

Delivery withinTerm 1

z

erroneous,

8-2-700. Srida Anushka Pride , Road

No.12, Banjara Hills, HYderabad -

500 034

Mobile/ Tel No: 9885021555 /o4o- 2 3 09793 6/ 98 48237 L3 I

Fax No (if anY)r 0091-040-

23095071

Email: md,[email protected]

saiparentrals@gmail,com

Vendor NameSAI PARENTERALS PvT LTD

Vendor Name

SIGNATUREINDUSTRIES

Fax No (if anY)3 0

Email:[email protected]

Vendor l{ameTABLETS (INDIA) LIMITED

Mobile/ Tel No: 9600152152 /044 - 42050186

Fax No (if anY): 044 - 28589090


=f1# 72, Marshalls noaO, ':navgl. f,pcentre" R A Building, 4Bl FlffEgmore, Chennai - 600 008


of dispatch) of supPlY

weeks (of the actual date


basis

Term 1

GST as applicable will be extra exce

where no tax has been aPProved'

pt for itemsTerm 2

at any time documents submitted/the tender is

award will beinformation given bY the firm in

ca

be

IfTerm 3

(of the actual date

FOR Destination

where

the tender is

award will be

for items

submitted/

)ctly.

Delivery within

of dispatch) of6(six) weeks

supply order

(of the actual date

on FOR Destination

basis

Term 1

be extra except for itemsle

approved.

informationfound to be

cancelled.

submi$edithe tender is

award will be

ntsmedocutimeIf at anyinrmRtheiven byI

theneouserrofalse/

Term 3


Page 14 of 17

310, 3rd Floor T.V Industrial Estate

S.K Ahire Marg Worli Mumbai 30

lYaharahstra

Mobile/ Tel No: 9930212908 /022-66261400

Term 1

basis

of supply order onweek.s

of dispatch)

been approved.GSTTerm 2

to

timeatIftnthe firmbygiven

thebe false/

Term 4

a ,

Vendor NameTHEMIS MEDICARE LIMITED

Ll I L2,Udyog Nagar,S.V. Road,

Goregaon(W),Mumbai-400 104

Mobile/ Tel No: 9022951026 /91-22-67607080

Fax No (if any): 91

67607070128746621

Email:

Plot No. 76, ISector 82. MO

gm.logistics@un

Vendor NameUs\, PRTVATE LIMIIED

Arvind Vitthal Gandhi Chowk, B.S'D

Marg, Govandi Station Road,

Mumbai - 400088

Mobile/ Tel Nor 9004084309 /022 25564048 I 987 1594946

Fax No (if any): 022 25584025


[email protected]

S ICcom



basis






cancelled.

Term 3

tou

x) weeks (of the actual date

rly order on FOR Destination

xtra except for itemsproved.

GST as

submitted/tender is

will befa

Term 1



where no tax has been approved.Term 2

&rt3


Iffirm in the tender is

cancelled.



Vendor NameUnimarck Pharma (India) Ltd


9216716800 /0172 2244500

Fax No (if any):Email:manager,mdoffice@unimarckpharma,com

Term 2

r

Term 1

lbasis

where no tax has been

aDlTerm 2


i nformatiori

found to be

cancelled.

Term 3

Term 4 Supply to be made

si,EC

,-l

r$Delivery within 6(six) weeks (of the actual date

-n-rTerm

Page 15 of 17

Vendol Name

VIRCHOW BIIOTECH PvT LTD

Plot No. 319 & 320, 3rd

FloorswamyAyyappa CooP. Housing

Society, Madhapur, Hyderabad 500

081

Mobile/ Tel No:

88791 10909/o97ooou8.2o I+9140-23119481+91-40-23119486

3rd floor, North

No. 2, BanjaraHil

Telangana - 500055

Mobile/ Tel No: 9849745578 /40-6608-6608

Fax No (if any): 40-6608-6699

Email : [email protected]

Mobile/ Tel No:9820360019/981 rt297 0t I022-68311100

Fax No (if anY): 022-28390733


[email protected]@hotmail.com

A 303/312 Floral Deck Plaza, OIf .i..

Central MIDC Road, Andheri (EirsQ, ,,l

Mumbai-400093



basis





bejalse/-e rroneousr the award will be

5


iio.fOR DestinationithinD ry

ofd S tch)pa

has been approved.

Iwhe onre

Ifo temsexce pt

ca

m tteduS bf aat nyed tsrtenthe

bewaa rddfoun tonce led

-Term 3

Term 4

ithin 6(six) weeks (of the actual date


basis

GST,:aS aPF

whereho tawill be extra exce

66trin approved,

itemfor se pt

sx




cancelled

Term 3

Term 4 Supply to be made directlY

Fax No (if any): Fax No:

23119486.

Email : strambhu.s@virchowpharma,com

[email protected]

vendor NameVIVIMED LABS LIMITED

.Building, Roiid

Hydeiiabad,

Vendor l{ameWALI.ACE PHARMACEUTICALS

PvT. LTD

Term 1' 6(six) weeks (of the actual date

basis

Term 2

by the firm inerroneous, the

documentstimegiven

Supply to..be made directly.N

Term 1

lerm z

Page 16 of 17

Mobite/ Tel No: 98202107013 /022-77596790 * -"&. :,,-i-E f 'tg -

i-L IEFax No (if anY): o2826Qp! L=,Email: [email protected]

Vendor Namewockhardt Limited

Wockhardt Tower, C2, G Blocls

Bandra Kurla ComPlex, Bandra East,

Mumbai - 51

Vendor NameZENITH DRUG PvT

7215 I.4uradpura(

Road Near Kalaria

453001

Mobile/ Tel No

8435501867

Fax No (if anY):

Email: info@zenith

Vendor Name

Zim Laboratories Limited

B-LUZZ, MIDC Area, Kalmeshwar-

441501 Dist. NagPur

Fax No (if any): 07118-271480


tendercell@zimlab,in

[email protected]

Mobile/ Tel No: 9818578rr? g to7tL8-27r4t01480 * *J



basis


D{If at any time documents submitted/

i nformatio n s iven by the fl rm n the tender is

be e award I I be

Term 4

x) weeks (of the

)ly order on FOR

actual date

Destination

GST asTerm 2

Lfor itemsextra exce Pt

)proved.

submitted/tender is

will be

:ctly.


(of the actual date


no tax has been awhereTerm 2


Page L7 of 77

!

a

r,

,


Term 3

a

basis

Dellvery within

of dispatch)

where no tax has been

weeks6(six)

basis

1

If submitted/documentsistendertn theflrm

bewillawardthe

3

INDEX 146C

SNo Item Description Page no

1 119

Povidone Vaginal Tab/Gp-Each Tab Ca to contain: Povidone Iodine 200 1

2 724

3 227Miconazole Cream-

Each Tube to contain: Miconazole Nitrate 2 o/o

224

nzoa

25o/ocontain: 2

5 229Flucinolone Oint-'Each

tube to cdhtain: Flucinolone Aceton ide 0.0250/o W/W 2

6 240

White Soft Paraffin-Each Pack to contain: White Soft Paraffin 2

7 260

Alfa Calcidol Tab/Cap-

Each TablCap contain: Alfa calcidol 0.25mc9. 3

8 26s

ne mglami 4mg.

3

9 272

Potassium Chloride Liquid-Each 15ml to contain: Potassium Chloride 1.5qm 4

10 394

Clotrimazole Lotion-

Each ml to contain: Clotrimazole 10mg 4

11 395

Clotri, Beclometh Oint-Each tube to contain: ClotrimazoleDipropionate 0.25m9

10mg, Beclomethasone

4

72 448Permethrin 5olo Cream-

Each Tube to contain: Permethrin 5% 5

13 45tVit. D3-200 IU, Vit, 812- 2.5 mcg., Calcium

5

t4 464

Erythropoietin IEach Pack to10000 Units

man Erythropoietin

5

15 480

Mupirocin Oint-

Each Tube to contain: Mupirocin 2olo 6

-LO 496

Vit. B Complex Syp-

Each 5ml to contain: Vit. A 2500 IU, Cholecalciferol 200 IU,Thiamine 2eg;rRiboflavin,1mg, Pyridoxine lirrg, Niaotinaminde15mg, Ascorbic Acid 50 mg, D -Panthenol 2.5mg,Cyanocobalamin lmcg, Citrus Bioflavonoid Compound 5mg. 6

501

Vit. B Complex + Vit.C Syp-

Each 5ml to contain: Thiamine 2 mg, Riboflavin 2.54 mg,Pyridoxine 2 mg, Niacinamide 20 mg, D-Panthenol 6 mg,Ascorbic Acid 75 mg 7

18 510

Metronidazole + Povidone lodine Oint-Each Tube to contain: Metronidazole 1ol0, Povidone lodine 5% 7

553

Flavoxate Tab/Cap-Each Tab/Gp to contain: Flavoxate Hydrochloride 200 mq. 7

Page 1 of 6

ItemNo.

Cyproheptadine Tab/Cap-Each Tab/Gp to contain: Cyproheptadine 4mq. 1

1

4

77

19

INDEX 146C

SNo ItemNo.

Item Description Page no

20 595

Calcuim (Absorbable) Tab/Cap-

Each Tab/Cap to contain: Elemental Calcium 150m9. (In theform Of Glcium Hydroxide and Calcium Oxide and Pretreated

with Heated Algae) 8

21 1135

Isoxsuprine SR Tab/Gp-Each SR Tab/Cap to contain: Isoxsuprine Hcl 40 mg. 8

22 1737

carboprost Inj-Each ml to contain: Carboprost 0.25m9. 8

23 1145

Fexofenadine Tab/Gp-Each Tab/Gp to contain: Fexofenadine 120m9 9

24 t24t

Salicylic Acid Oint-

Each Tube to contain: Salicylic Acid 60/o wlw, Benzoic Acid 120lo

Vw, Hydrocortisone Acetate 0.5olo wlw 9

25

Urea+ Lactic Acid Cream-

Each Jar to contain: Urea 12olo w/w, Lactic Acid 60lo w/w, Glycine

3o/o wlw, Ammonium Chloride 0.50/o w/w, Sod. Chloride 0.5olo

w/w, Potassium Chloride 0.50/o w/w, Glcium Lactate 0.5% w/w,Magnesium Chloride 0.30/o w/w, Sod. Dihydrogen Phosphate 0.5

10

)A 7252

Clob€tasol Oint-

Each Tube to contain: Clobetasol Propionate 0.050/o 10

Tretinoin Cream-

Each Tube to contain: Tretinoin (Trans Retionic Acid) 0.05o/o 10

28 177tGlycerine-

Each Bott to contain: Glycerine 500 gm 11

29 1308

Iron And Vitamin Tab/Cap-

Each Tab/Cap to contain: Ferrous Fumarate 350 mg, Vit. C 150

mq, Vit 812 - 15 mcq, Folic Acid 1.5 mq. 11

30 t3t2

iron + Vitamin Syp-

Each 5ml to contain : Colloidal Iron Eqv to Elemental lron 250

mq, Folic Acid 500 mcq, Vitamin 812- 5mcq 11

1313

Iron And Folic Acid Drop-Each ml to contain: Colloidal lron Eqv. to Elemental Iron 25 mg,

Lysine Hydrochloride 200 mg,Vit. B12- 5 mcA, Folic Acid 200

mcq t2

32 1386

Sodium Fusidate Oint-

Each lgm to contain: Sodium Fusidate 20mg tz

33

Mecobalamine + Lipoic Acid Tab/Cap - Each Tab/Gp to contain:

Mecobalamine 0.5mq, Alpha Lipoic Acid 100mq t2

J.t 1391

Acyclovir Cream-

Each Tube to contain: Acyclovir 5olo W/w 13

35 1397

Clotrimazole Gel-

Each Tube to contain:Clotrim azole 2o/o wlw

Page 2 of 6

7242

27 1257

1388

13

SNo ItemNo.


36 1403

Anti Oxidant Tab/Gp-Each Tab/Cap to contain;Carotenoids And Micronutrients FromCarrots 100m9 (Eqv. To 100mcg Of Grotenoids Glculated As

Beta Carotene) Beta Carotene 7.5olo Dispersion 40mg (NaturalGrotenoids), Vit. C 150m9, Vit. E Acetate 25m9, SeleniumDioxide 75mcg (Eqv To 45.9mcg Of Selenium), Zinc Sulphate

To 15.9m tnc

37 1424

Tamsulosine:Tab/Cap-

Each Tablcap to contain: TamRelease)

sulosine 0i4mg (As Modified

74

38 7475

Tamsulosin + Dutasteride Tab/Cap-Each Tab/ Cap to contain: Tamsulosin 0.4m9 (As ModifiedRelease) + Dutasteride t4

39 7436

[4ultivitamin Drop-Each ml to contain: Vitamin A Concentrate (As palmitate) OilyForm:3000 IU, Cholecalciferol 400 IU, Ascorbic Acid 40mg,Thiamine Mononitrate:2m9, Riboflavin Sodium Phosphate Eqv

To Riboflavin: lmg, Nicotinamide 10,5mg, PyridoxineHydrochloride:1mg, D.Panthenol 3mg, Tocopheryl Acetate5.25IU, Flavoured Aqueous Base(Appropriate Overages OfVitapins Added To Compensate For Loss On Storaqe) 15

40 1438

Iron InjEach m 15

4t 1440

Ferac rylum Gel

Each tub€ to

1441

+ nSu

Phial to contain: Zinc Bacitracin 400U, Polymyxin B

ate 5000 ate 3400U 16

43

Dutasteride Tab/Cap-cdch Tab/Cap to conta in: Dutasteride 0.5 mq 16

44 7579

l'4ix Lactobacilll Vaginal Tab/Cap-Each Vaginal Tab/Cap to contain: Mix(1. Brevis,L. Salivarious And L.Plantarum ) 10E9

Lactobacilli

t7

45 1612

Sertaconazole Cream-

Each Tube to contain: Sertaconazole Nitrate 2olo Cream 77

46 t617

Clobetasol+Salicylic Acid Oint-Each Tube to contain: Cl

Salirylic Acid 60/o wlw.obetasol Rmpionate '0,050/o w/w,

77

47 1633

MethylocobalaminEach ml to contain: Meth locobalamin 500 m 77

48 1685

Dexchlorpheniramine SR Tab/Gp-Each SR Tab/Gp to contain: Dexchlorpheniramine 6mg 18

49 1686

Fexofenadine Tab/Cap-Each Ta Cap to contain: Fexofenadine 180m9 18

50 1587

Loratidine Tab/Cap-

Each Tab/Cap to contain: Loratidine 10mg 18

Page 3 of 6

INDEX 146C

13

16

42

1577

INDEX 146C

SNo ItemNo.


51 t703Terbinafine Ointment/ Cream -

Each tube to contain; Terbinafine Hcl. 1olo 19

52 !704

Acne Gel-

Each Tube to contain: Adapalene 0.1olo IPIBP/USP etc Ww (As

Microsheres) Clindamycin Phosphate IPlBP/USP etc Equivalent

To Clindamycin 1.00/o w/w in an Aqueous Gel Base -Q.S. 19

53 77L1

Sertaconazole Nitrate Lotion-

Each Phial to contain: Sertaconazole Nltrate 2% w/vPropylene

Glycol Base Qs 19

54 1712

Benzoyl Peroxide GeF

Each pack to contain: Benzoyl Peroxide 2.50/0

55 1718

Adapelene Gel-

Each Tube to contain: Adapelene 0.1 percent

56 7723

Isopropyl Alcohol Spray-Each pack to contain: Isopropyl Alcohol-S5o/o w/w, Purified

Water- 100/o w/w, Propellant Hydrocarbon-3s% w/w 20

57 7793

Calcium Tab/Cap-

Each Tab/Cap to contain: Calcium Citrate Malate Equivalent toElemental Calcium 250m9, Calcitriol 0.25 mcg,Vitamin K2-7

50mcq. 21

58 1887

Sildenafil Tab/Gp -Each Tab/Cap to contain: Sildenafil 50mg 2t

59 1940

Ketoconazole Lotion-

Each Bott to contain: Ketoconazole 2o/o wlv 22

60 7942

Clotrimazole Dusting Powder-

Each pack to contain: Clotrimazole Dusting Powder 1 o/ow/w 22

61 t944Luliconazole Cream-

Each Tube to contain: Luliconazole 1olo

62 1946

Minoxidil Lotion-Each Bott to contain: Minoxidil 2olo

63 t947lYinoxidil Lotion-

Each Bott to contain: Minoxidil 5% 23

o.t 1956

Paraffin Gauze-

Each Piece to contain: Paraffin Guaze 10cm X 10cm 24

1958

Multi Vitamin Tab/Cap-

Each Hard Gelatin Tab/Cap to contain: Ferrous Fumarate I.PEqv. to Elemental Iron 30 mg, Folic Acid I.P 250 mcg, Zinc

Sulphate Monohydrate B.P. Eqv. to Zinc 20 mg , Thiamine

Mononitrate (Vit. 81) I.P. 1.2 mg, Riboflavin (Vit. 82) LP. 1.2

mg, Niacinamide LP.10 mg, Pyridoxine Hydrochloride (Vit. 86)

I.P. 1 mg , Cyanocobalamin (Vit. 812) LP. 2.5 mcg Ascorbic Acid

Coated (Vit. C) I.P. 40 mcs 24

Page 4 of 5

t20

20

23

23

65

INDEX 146C

SNo Item Description Page no

66 1959

Multi Vitamin With Amino Acid Tab/Cap-Each Tab/Cap to contain: L-Arginine Hydrochloride USp13.28m9, L-Histidine Hydrochloride H20 Bp 3.71mg, L-

Isoleucine USP 5.9m9, L-Leucine USP 18.3mg, L-LysineHydrochoride USP 25.0m9, DL-N4ethionine BP 18.4mg, L-Phenylalanine USP 5mg, L-Threonine USP 4.2mg, L-TryptophanU$-P 5mg, L-Valine USP 6.7m9, s-Hydroxy Anthranilic Acid HCL

Q,.2mg, Chol,ecalciferol IP. 200 IU, Nicotinamide Ip 25mg,Pyridoxine Hydrochloride IP 1.5mg, Methylcobalamin 500mcg,'Biotin

USP 30mcg, Folic Acid'IP 0.75mg, Copper Sulphate Bi4mg, Ferrous Sulphate IP 20.5mg, Magnesium Sulphate Ip7.43m9, Manganese Sulphate BP 1.4m9, Potassium Iodide Ip0 1 mg Sod u m Se len ite BP 10 0mcg Zin Su pha te IP 1 5 mgCh rom u m coti nate 2 24

67 7962

Ferrous Ascorbate With Aminoacids & Zinc TablGp-Each film coated Tab/Cap to contain:Ferrous Ascorbateequivalent to elemental Iron 100mg, Methylcobalamin 1OOomcg,

Fo ic Acid 5ms L.-H istid ne Hcl H 20 4mg, L - Lysine cl 25mgG ne Iidox n Hcl 1 5 m Z nc Su 50 25

68 2049

Ferric Carboxy MaItose Eqv, To Elemental Iroir 50 mg Inj-ch ml to co in: Fe rric Grboxy Maltose Eqv. to Elemental

Iron 50mq 25

69 2103

Feracrylum With Centbucrid ine Hydrochloride Gel-Each Tube to contain: Feracrylum 3o/o w/w, Centbucridine O.5olo

w/w (As Centbucridine Hcl) Water Miscible Base e.S. 25Posaconazole So n-Each Ph ta I to contain Posaconazo o ra Sol ml 26

77 27t2

Each Film Coated Tab/Cap to contain:Calcium Aspatate 500m9, Calcium Orotate 500mg, Calcitirol0.25mc9, Zinc(As Zinc Sulphate Monohydrtae IP) 7.5mg,I4agnesium Hydroxide IP 50mg. Hydroxocobalamin IP 100mcg,Folic Acid IP 1.5m9, Excepients q.S. 26

72

Each Tab/Cap to contain:Atorvastatin Calcium IP Equivalent to Atorvastatin 1omg,Methylcobalamin 500 mcg, Folic Acid IP 5mg , Pyridoxine Hcl Ip10

73 27t5

Hematinic With Amino Acids,Vitamins And Zinc Syrup:Each 10 ml to contain : Ferrous Glycine Sulphate.216.5 mg, L-Histidine Hydrochloride H2o BP 4 mg, L- Lysine HydrochlorideUSP 25 m9;.Pyridoxine Hydrochloride IP 1.5 mg, NicotinamideIP 25 mg, Folic Acid IP 0.5 mg, Cyanocobalamin IP 2.5 mcg,Zinc Ascorbate 50 27

74 271.6

Iprifl avone,Calcium,Vit D3 Tab/Gp:Each Film Coated Tab/Cap to contain: Calcium Carbonate 1.0gm From Organic Source(Oyster Shell) Equivalent to ElementalGlcium 400 m I riflavone 300 Cholecalciferol IP 200 IU 27

75 2246 27

Page 5 of 6

ItemNo.

70 7104

27t3 26

Silver Nitrate GeF

Each Tube to contain: Silver Nitrate Gel 0.2olo w/w

INDEX 146C

Page noItem DescriPtionItemNo.

SNo

28in - Urea Debridi OinmentPa224776

28Methylcobalamin Tab/CaP:

lamin 1500Each T G to contain:240277

28

Sertaconazole Nitrate

Each Bott to contain

Powder-

: Sertaconazole Nitrate 2olo w/w ,Talc IP

240378

29240679

29Each Tube to contain: Fluocinolone Acetonide 0.025o/o,

oi Cream-n++neuoct

Neo n Sul hate 0.50lo e Nitrate 2.0o/o240880

30Ketoconazole

Each T240981

30

Mo

247782

31ntain : Human Chorion

1157b83

31n: Vit.

184

311485

32408a86

32IUn408d87

32Origin)/

in 5.

Human

Each Ca

Somatro509a88

33

PaDer Adhesive TaPe-puil, eAnuiir" Tape Hypoallergenic With Acrylate Adhesive

2.5cmx9.14m546a89

33

Paper

PaperhesiveAd

546b90

34Finasteride Tab/CaP-

to conta in: Finasteride 5Each558b91

Page 6 of 6

Kid Tab/CaP-

Montelukast 4mg & LevocetrizineLevocetrizi ne

contain:toEach Tab/Cap

5000

Tab/CapuleVitamin E Tab/CaP-

Eto (AlphaEach

Ebastine Tab/CaP-

Each

Recombinant Human Erythropoietin 2000toInj-

contain:PFSEach

ErythroPoietinRecombinantInj-

3000Humancontain:PFS toEach

I

a7(

:oo

Employes' Sbte Insurancc Corporation

Rate Schedule of Running Rate Contract No. U-25/121142C-L46C|z0tg-Med V FOR RC 146C

Valid from Thursday, October l4th 2O2L to Tuesday, October 31st 2023

PackingDrug Descriptionftem No

Firm RaE/unit

FirmPacking

Prefercnce De*rtption of sbtes acepEd

119 Povidone Vaginal Tab/Cap-

Each Tab/Cap to contain: Povidone Iodine 200m9.

1 Tab/Cap

10 Tabs FIRST SAME AS IN ITEM

Rupees Two AND Paise Seven Zeto Only

t24 Cyproheptadine Tab/Cap-

Each Tab/Cap to contain: Cyproheptadine 4mg,

1 Tab/Cap

MicronPharmaceuticals

Zenith Drugs Pt t.Ltd.

O.22Perl Tab/Cap

10 Tabs FIRST PERTTOL

SAME AS IN ITEM

Rupees Nil AND Paise Two TWo OnlY

221 It4iconazole Cream-

Each Tube to contain: Miconazole Nitrate 2 o/o

15gm TubE FIRST SAME AS IN ITEM

Bal Pharma Limited 16.29 Per

15 9m Tube

Rupe* Eleven AND Paise Four Thrce Only

12.60Per 159mTube SECOND SAMEASINITEM15 gm Tube

Rupees Twelve AIID Paise Six Zeto Only

159mTube THIRD CANDIZOLE 15GM

SAME AS IN rTEMz

Page 1of 34

Firm Name

Themis MedicareLimited


2,7O Perl Tab/Cap

U.43 Per15 9m Tube

tur

15 gm Tube

/,

Rupees Sixhen AND Pai* Two Nine OnlL

f1*

Employees' State fnsurance Corporation

Rate Schedule of Running Rate Contract No. U-25/121142C-L46C|zOLg-Med V FOR RC 146C

Valid from Thurcday, October l4th 2O2L to Tuesday, October 31st 2023

Item No Drug Description Packing

Firm Name Firm RaE/unit Packing

Prefercnce Description of stores ac@pted

224 Benzyl Benzoate Application-

Each Bott to contain:Benzyl Benzoate 25olo

Rupees One Hundred Thirteen AND Paise Four Zerc Only

15 gm Tube



Goldwin MedicareLtd.

113.40 Per1 Ltr Bott

13.95 Per15 gm Tube

91.70 Per500 gm Pack

Rupees Thirteen AND Paise Nine Five Only

240 White Soft Paraffin-

Each Pack to contain: White Soft Paraffin500 gm Pack

5009mPack

FIRST SAME AS IN ITEM

Rupees Ninety One AND Pai* Seven Zeru Onlya

1 Ltr Bottle

1 Ltr Bottle FIR.ST SAME AS IN ITEM

229 Flucinolone Oint-

Each tube to contain: Flucinolone Acetonide 0.025olo

15gm Tube FIRST SAME AS IN ITEM

PaBe 2 of 34

PackingDrug Descriptionftum No

Firm Name Firm Rate/unit Packing

Prefercnce De*ription of storcs acepted

Alfa Calcidol Tab/Cap-

Each Tab/Cap to contain: Alfa Calcidol 0.25mc4.

1 Tab/Cap

0.65 Perl Tab/Cap

10 Caps FIRST

2ml Amp FIRST

DL-ALPHA 0.25SAME AS IN ITEM

POLYBIONSAME AS IN ITEM

Panacea BiotecPharma Limited

MacleodsPharmaceuticalsLimited

Procter & GambleHealth Limited(Formerely KnownAs Merck Limited)

Rupees Nil AIVD Paise Six Six Onlf

O.74 Per 10 Caps SECOND ALPHADOT

l Tab/Cap SAME AS IN ITEM

Rupees Nil AND Paise Seven Four Only

1.09 Per 10 Caps THIRD ALFACAL


Rupees One AND Pai* Zero Nine Only

265 Vitamin IniEach 2ml to contain: Thiamine 10m9. Riboflavin 4

mg. Nicotinamide 40 mg. Cyanocobalamine 8 mca.

Pyridoxine 4mg. D-Panthenol 6mg.Benzyl Alcohol

0.9o/o

2 ml Amp

Page 3 of 34

Employees' State fnsuran@ Corporation

Rate Schedule of Running Rate Contract No. U-25/12l142C-l46Cl2OL9-Med V FOR RC 146C

Valid from Thursday, October 14th 2021 to Tuesday, October 31't 2023

260

Jyoti CapsulationsPvt. Ltd

4.75 Per2 m! Amp

Rupees Four AND Paise Seven Five Only

4,a*/:

Drug Description Packing

Firm Name Firm Rate/unit

FirmPacking

Prefercnce

272 Potassium Chloride Liquid-

Each 15ml to contain: Potassium Chloride 1.59m

200 ml Bottle

Zenith Drugs Art.Ltd.

Franco-IndianRemedies Pvt Ltd

Hindustanla boratoriesLimited

Franco-IndianPharmaceuticalsArt Ltd

38,50 Per 200m1200 ml Bott Botd€

10.99 Per15 ml Bott

200m1Bottle

15mlBottle


Rupees Twenty Nine AND Paise Eight One Only

Rupes Thirty Eight AND Pai* Five Zeru Only

394 Clotrimazole Lotion-

Each ml to contain: Clotrimazole 10mg

15 ml Bottle

FIRST

Rupees Ten AND Paise Nine Nine Only

SECOND KEYLYTE

SAME AS IN ITEM

SURFAZ SOLUTIONSAME AS tN ITEM

SECOND SAME AS IN ITEM

Rupees Thirt@n AlyD Pai* Nine Four Only

Clotri, Beclometh Oint-

Each tube to contaln: Clotrimazole 10m9,

Beclomethasone Dipropionate 0.25m9

10 gm Tube

13.94 Per 15ml15 ml Bott Bottle

12.83 Per10 gm Tube

Surfaz-B CreamSAME AS IN ITEM

Rupees Twelve AIID Paise Eight Thrce Only

PaBe 4 of 34

Employees' Sfa,te fnsurance Corporation

Rate Schedule of Running Rate Contract No. U-25/121142C-L46C|zOL9-Med V FOR RC 145C

Valid from Thursday, October 14th 2021 to Tuesday, October 31"t 2023

ftem No

Dexription of sbtes ac@pfud

WallacePharmaceuticalsPrrt. Ltd.

29.81 Per200 ml Bott

109m Tube FIRST

,/*r.r".--t-

395


Rate schedule of Running Rate contract No.u-251,,21142C-t46Cl2OL9-Med V FOR RC 146C

Valid from Thursday, October 14th 2021 to Tuesday, October 31st 2023

ftem No Drug Description Packing

PackingDe*ription of stores accepted

448 Permethrin 5olo Cream-

Each Tube to contain: Permethrin 5olo

30 gm Tube

Zenith Drugs hrt.ttd.

23.rt8 Per200 ml Bott

11,61 Per30 gm Tube

Rupees Eleven AND Paise Six One Only

l4.25Per 3ogmTube SECOND SIGNASCAB30 gm Tube SAME AS IN ITEM

RUF* Fourteen AND Paise Two Five Only

Calcium Syp-

Each 5ml to contain: Vit. D3-200 IU, Vit. 812- 2.5

mcg., Calcium -82 mg.

200 ml Bottle

200m1

Bottle

RENOCEL 1OOOO IUSAME AS IN ITEM

Rupees Twenty Thrce AND Paise Four Eight Only

Erythropoietin Inj-Each Pack to contain: Recombinant Human

Efihropoietin 10000 Units

1 pack

1ml PFS FIRST

Wockhardt Ltd, 419.00 Per 1ml PFS SECOND WEPOX 10O0O

1 pack SAME AS IN ITEM

Rupees Four Hundted Nineben OnlU

Firm Name Firm RaE/unit

Prefercnce

HabPharmaceuticals &Research Ltd

309m Tube FIRST SAME AS IN ITEM

45t

GalphaLaboratoriesLimited

258.89 Per1 pack

FIRST NEW GALCAL 812SAME AS IN ITEM

464

IntasPharmaceuticalsLtd

Rupees Two Hundrcd Fifry Eight AND Pai* Eight Nine Only

Page 5 of 34

J.-/r-'-Y/.-

Packingftem No Drug Description

Firm Name Firm Rate,/unit Packing

Prefercnce

480 Mupirocin Oint-

Each Tube to contain: Mupirocin 2olo

5 gm Tube

sgm Tube FIR.ST SAME AS IN ITEMSignatur€PhytochemicalIndustries

Vivimed Labs Ltd.

HindustanLaboratoriesLimited

68.21 Per200 m! Bott

15.90 Per5 gm Tube

Rupees Fifuen AND Paie Nine zero Onlye

t6.77 Per5 gm Tube

5gm Tube SECOND SAME AS IN ITEM

Ruryes Sixteen AND Paise Seven *ven Only

18.89 Per 5gmTube THIRD MUPM5 gm Tube SAME AS IN ITEM

Ruryes Eighben AND Paise Eight Nine Only

2OOml

BottleFIRST HIVITAMINE

SAME AS IN ITEM

Rupees SW Eight AND Paise Two One Only?

496 Vit. B Complex Syp-

Each 5ml to contain: Vit. A 2500 IU, Cholecalciferol

200 IU, Thiamine 2mg, Riboflavin 1mg, Pyridoxine

1mg, Nicotinaminde 15m9, Ascorbic Acid 50 mg, D -

Panthenol 2.5m9, Cyanocobalamin lmcg, Citrus

Biofl avonoid Compound 5mg.

200 ml Bottle

Page 6 of 34

Employes' State fnsurance Corporation

Rate Schedule of Running Rate Contract No. U-25lL2lL42C-L46C|zOL9-Med V FOR RC 146C


De*rtpfion of slorcs acepd

BiodealPharmaceuticalsArt. Ltd.

e


Rate Schedule of Running Rate Contract No. U-25l12l142C-146C12OLg-Med V FOR RC 146C

Valid from Thursday, October L4th 2O2l to Tuesday, October 31't 2023


Firm NamePacking

Preference Description of stores accepted

501 Vit. B Complex + Vit.C Syp-

Each 5ml to contain: Thiamine 2 mg, Riboflavin 2.54mg, Pyridoxine 2 mg, Niacinamide 20 mg, D-

Panthenol 6 mg, Ascorbic Acid 75 mq

120 ml Bottle

Pfizer Limited 18.29 Per120 ml Bott

120m1Bottle

FIRST BECOSUTES SYRUP 12OMLSAME AS IN ITEM

Ruryes Nineten AND Paise Four Eight Only

510 Metronidazole + Povidone Iodine Oint-Each Tube to contain: Metronidazole 1%o,

Povidone Iodine 5olo

15 gm Tube

GalphaLabontoriesLimited

13.85 Per15 gm Tube


Rupees Thirten AND Paise Eight Five Only

14.2O Per15 gm Tube

Ruryes Fouften AND Pai* Four Zeto Only

553 Flavoxate Tab/Cap-

Each Tab/Cap to contain: Flavoxate Hydrochloride200 mg.

l Tab/Cap

15gm Tub€ SECOND TRIDIN PLUS

SAME AS IN ITEM

10 Tabs FIRST FLAVATE

SAME AS IN ITEM

Ru$es Two AND Paise Seven Zeto

Page 7 of 34

oilb

Firm Rate/unit


Rupees Eighteen AND Paise Two Nine Only

19.48 Per 12Om! SECOND SAMEASIN TTEM120 ml Bott Eottle


OverseasHealthcare Pvt Ltd

2.7O Perl Tab/Cap

Employees' State Insu ra nce Cotporation

Rate Schedule of Running Rate Contract No. U-25llZlL42C'l46Clz0l9-Med V FOR RC 146C

Valid from Thursday, October t4th 2021 to Tuesday, October 31't 2023


Firm Name Firm RaE,/unit Packing

Prefercnce Dexription of stotes accepted

595 Calcuim (Absorbable) Tab/Cap-

Each Tab/Cap to contain: Elemental Calcium 150m9.

(In the form Of Calcium Hydroxide and Calcium

Oxide and Pretreated with Heated Algae)

1 Tab/Cap

Rupees Four AND Paise Five Seven Only

1135 1 Tab/Cap

10 Tabs FIRST SAME AS IN ITEMHabPharmaceuticals &Research Ltd


15 Caps FIRST

FIRST

Triple A CalSAME AS IN ITEM

ENDOPROST 2sOMCG

SAME AS IN ITEM

0.83 Perl Tab/Cap

Rupees TWo AND Paise One Six OnlY

Ll37 Carboprost Inj-Each ml to contain: Carboprost 0.25m9.

1 ml Vial/Amp

Bharat Serums AndVaccines Limited

42.50 Per1mlVial/Amp

Rupees Forty Two AND Paise Five Zero Only

Page 8 of 34

Isoxsuprine SR Tab/Cap-

Each SR Tab/Cap to contain: Isoxsuprine Hcl 40 mg.

USV Private Limited 4.57 Petl Tab/Cap

Rupees Nil AND Paise Eight Three Only

2.15 Per 10 Tabs SECOND PREGNIN RETARD

l Tab/CaP SAME AS IN ITEM

l Vial


Rate Schedule of Running Rate Contract No. U-25/12l142C-L46C|20l9-Med V FOR RC 146C

Valid from Thursday, October 14th 2021 to Tuesday, October 31,t 2023


Firm Rate/unit

FirmPacking

Prefercnce Description of storcs acepted

1145 Fexofenadine Tab/Cap-

Each Tab/Cap to contain: Fexofenadine 120m9.

l Tab/Cap

Signatur€Phytochemica!Industries

Psychotropics IndiaLimited

1.40 Perl Tab/Cap

1.68 Per 10 Tabs SECOND FFNpIt 120l Tab/Cap SAME AS IN ITEM

Rupees One AND Pai* Six Eight Only

1.99 Per lOTabs THIRD HISTAFREE-12ol Tab/Cap SAME AS IN ITEM

MediforceHealthcare PravateLtd

East IndaaPharmaceuticalWorks Limited

53.00 Per15 9m Tub€

15gm Tube FIRST KERALIN

SAME AS rN ITElg,

Rupes One AIVD Pai* lvine Nine Only

l24r Salirylic Acid Oint-Each Tube to contain: Salicylic Acid 6010 w/w, BenzoicAcid 72o/o w/w, Hydrocortisone Acetate 0.5olo w/w

15 gm Tube

Rupees Fifty Three Only4

Page 9 of 34

I ttem No I

Firm lVame

Rupees One AND Pai* FourZerc Only

10 Tabs FIRST SAME AS IN ITEM

f*?


Rate Schedule of Running Rate Contract No. U-25l121142C-L46C|z0t9-Med V FOR RC 146C

Valid from Thursday, October 14th 2021 to Tuesday, October 31st 2023

fhm No Drug Description Packing

Firm Name Firm RaE/unit Packinq

Preference

t242 Urea+ Lactic Acid Cream-

Each Jar to contaln: Urea LZo/o w/w, Lactic Acid 60lo

w/w, Glycine 3o/o wlw, Ammonium Chloride 0.5olo

w/w, Sod. Chloride 0.5o/o wlw, Potassium Chloride

0.5o/o wlw, Calcium Lactate 0.5o/o wlw, Magnesium

Chloride 0.3o/owlw, Sod. Dihydrogen Phosphate 0.5o/o wlw

50gm to 75gm Jar

Rupees Nil AND Paise Eight One Only

10 gm Tube


0.81 Per

9m

75 gm rar FIRST U-RYL

SAME AS IN ITEM

TRETOINSAME AS IN ITEM


Ruwes *ven AND Paise Five Six Only

9.00 Per logm Tube SECOND SAME AS IN ITEM10 gm Tube

Rupees Nine Only

Tretinoin Cream-

Each Tube to contain:

Tretinoin (Trans Retionic Acid) 0.05o/o

20 gm Tube

Page 10 of 34

Description of stores accephd


Lark Laboratories(India) Ltd.

1252 Clobetasol Oint-

Each Tube to contain: Clobetasol Propionate 0.05o/o

7.55 Per10 gm Tube


38.50 Per20 gm Tube

209m Tube FIRST

t257

Rupees fhirty Eight AND Paise Five Zeru OnlL

J-il--*t:

Employees' State fnsurance CorPoration

Rate Schedule of Running Rate Contract No. U-25lLZlL42C-L46C|2OL9-Med V FOR RC 146C

Valid from Thursday, October L4n'2O2L to Tuesday, October 31"t 2023

PackingItem No Drug Description

Firm Ra@/unit Packing

Preference De*ription of stores accepted

l27t Glycerine-

Each Bott to contain: Glycerine 500 gm

500 gm Bottle


East IndiaPharmaceuticalWorks Limited

GalphaLaboratoriesLimited

51.01 Per5OO gm Bott

5009m FIRST SAME AS

SAME AS

IN ITEM

Rupees SiW One AND Paise Zerc One Only

3.42Perl Tab/Cap

FIRST FOTCIRON PLUS

SAME AS IN ITEM

FIRST TONOFERON SYP.47,LO Per 200m1

200 ml Bott Bottle

30

Iron + Vitamin Syp-

Each 5ml to contai

Iron 250 mg, Folic

200 ml Bottle

IN ITEM

Rupees FoilySeven AND Paise One Zero Only

Rupees Fifry Six AND Paise Two Eieht Onlf,

1308 Iron And Vitamin Tabi Cap-

Each Tab/Cap to contain: Fenous Fumarate 350 mg,

Vit. C 150 mg, Vit 812 - 15 mcg, Folic Acid 1.5 mg.

Page 11 of 34

Firm Name

1 Tab/Cap

Rupees Three AND Paise Four Two Only

L312

zim LaboratoriesLimited

55.28 Per 200m1 SECOND CHOCOFER + SYRUP

200 ml Bott Bottle SAME AS IN ITEM



Preference Description of stores accepted

1313 Iron And Folic Acid Drop-Each ml to contain: Colloidal Iron Eqv. to Elemental

Iron 25 mg, Lysine Hydrochloride 200 mg,Vit. 812- 5mcg, Folic Acid 200 mcg

15 ml

East IndiaPharmaceuticalWorks Limited

15ml

24.85 Per 15ml15 ml

FIRST FERROVIT DROPS

SAME AS IN ITEM

SECOND TONOFERON DROPS

SAME AS IN ITEM

Rupees TWenty Th,ee AND Paise Thto One Only

Rupees Twenty Four AllD Paise Eight Five Only

1386 Sodium Fusidate Oint-Each lgm to contain: Sodium Fusidate 20mq

5 gm Tube

WallacePharmaceuticalsPvt. Ltd.


USV Private Limited

19.80 Per5 gm Tube

24.2OPer sgmTube SECOND5 gm Tube


Rupes Nineten AND Paise EightZero Only

FUSIWAL OINTSAME AS IN ITEM

Rupees Twenty Four AND Paise Two Zeto Only

1388 Mecobalamine + Lipoic Acid Tab/Cap - Each Tab/Capto contain: Mecobalamine 0.5m9, Alpha Lipoic Acid

100m9

1 Tab/Cap

3.33 Per 10 Caps FIRST MECLOBICl Tab/Cap SAME AS IN ITEM

Rupees Three AND Paise Three Thrce Only

4.40 Per 10 Caps SECOND NEUVESCAl Tab/Cap SAME AS IN ITEM

Ruryes Four AND Paise Four Zerc Onlyz

Employees' State fnsunnce Corporation

Rate Schedule of Running Rate Contract No. U-25/12l142C-L46C12O19-Med V FOR RC 146C



23.2! Per15 ml


Page 12 of 341e,*/:



Dexription of stores ac@phd

Aryclovir Cream-

Each Tube to contain: Acyclovir 5o/o wlw5 9m Tube



13.50 Per5 gm Tube

sgm Tube FIRST SAME AS IN ITEM

Rupees Thirteen AND Paise Five Zero Only

14.85 Per sgm Tube SECOND SAME AS IN ITEM5 gm Tube

Rupees Foufteen AND Paise Eight Five Only

30 gm Tube

14.48 Per30 gm Tube


Rupees Fourteen AND Paise Four Eight Only


2.95 Perl Tab/Cap

CANATE

SAME AS IN ITEM

Rupees Two AND Paise Nine Five Only?,

1403 Anti Oxidant Tab/Cap-

Each Tab/Cap to contain:Carotenoids And

Micronutrients From Carrots 100m9 (Eqv. To 100mcg

Of Carotenoids Calculated As Beta Carotene) Beta

Carotene 7.5o/o Dispersion 40mg (Natural

Carotenoids), Vit. C 150m9, Vit. E Acetate 25m9,

Selenium Dioxide 75mcg (Eqv To 45.9mcg Of

Selenium), Zinc Sulphate 70mg (Eqv To 15.9m9

Zinc).

1 Tab/Cap

Page 13 of 34

Employees' State fnsura nce Corporation

Rate schedule of Running Rate contract No. u-25l12l142C-L46C|20t9-Med V FOR RC 146C

Valid from Thursday, October L4rh 2O2l to Tuesday, October 31"t 2023

Prefercnce

1391

1397 Clotrimazole Gel-

Each Tube to contain:Clotrimazole 2o/o wlw

Ajanta PharmaLimited

10 Tabs FIRST

fhm No Drug Description Packing


Preference Dercription of stores ac@pted

Tamsulosine Tab/Cap-

Each Tab/Cap to contain: Tamsulosine 0.4m9 (As

Modified Release)

1 Tab/Cap

OverseasHealthcare P\rt Ltd

zim LaboratoriesLimited

Modi MundipharmaPrivate Limited

0.90 Per

l Tab/CapURITINSAME AS IN ITEM

Rupees Nil AND Paise Nine Zeru Only

0.95 Per 10 Cap SECOND TAMSIN 0.4l Tab/Cap SAME AS IN ITEM,

Rupees Nil AIID Paise Nine Five Only

1.00 Per 10 Tabs THIRD TAMCONTIN 0.4l Tab/Cap SAME AS IN ITEM

Rupees One Only

L425 Tamsulosin + Dutasteride Tab/Cap-

Each Tabi Cap to contain: Tamsulosin 0.4m9 (As

Modified Release) + Dutasteride 0.5m9

l Tab/Cap

Cipla Limited

Modi MundipharmaPrivate Limited

1.06 Perl Tab/Cap

10 Tabs FIRST URMN D

SAME AS IN ITEM

Rupees One AND Pai* Zero Six Only

1.12 Per 15 Tabs SECOND URII'|AX D TAB

l Tab/Cap SAME AS tN ITEM

Rupees One AND Pai* One Two Only

l.42Per lOTabs THIRD TAMCONTIN-D


Rupees One AND Pai* Four Two Onll_

PaBe 14 of 34

Employees' Sbte fnsurance Corporation

Rate Schedule of Running Rate Contract No. U-25/12l142C-t46Cl20l9-Med V FOR RC 146C

Valid from Thursday, october 14th 2021 to Tuesday, October 31't 2023

L424

l0Tabs FIRST

OverseasHealthcare hrt Ltd

Employees' StaE fnsurance Corporation

Rate Schedule of Running Rate Contract No. U-25/12l142C-l46Cl2OL9-Med V FOR RC 146C

Valid from Thursday, October L4th 2O2t to Tuesday, October 315t 2023

Packingftem No Drug Descrtp on

Firm Rate/unit

FirmPacking

Prefercnce Dexription of storcs ac@pted

Multivitamin Drop-

Each ml to contain: Vitamin A Concentrate (As

Palmitate) Oily Form:3000 IU, Cholecalciferol 400 IU,

Ascorbic Acid 40m9, Thiamine Mononitrate:2m9,

Riboflavin Sodium Phosphate Eqv To Riboflavin:

lmg, Nicotinamide 10.5m9, Pyridoxine

Hydrochloride:1m9, D.Panthenol 3mg, Tocopheryl

Acetate 5.25IU, Flavoured Aqueous

Base(Appropriate Overages Of Vitamins Added To

Compensate For Loss On Storage)

10 ml Phial

Rupees Fifteen AND Pai* Two Zero Only

1438 Iron Inj-Each ml to contain: Iron Sucrose 20mg

5 ml Vial/Amp

Sai Parenterals hrt.Ltd.

Unimarck Pharma(r) Ltd

15.20 Per10 ml Phial

10ml Phial FIRST HNITAT PLUS

SAME AS I'{ ITEM


Ruryes Thirteen Only

5 ml Amp SECOND SAME AS IN ITEM

Rupees Fifteen AND Paise Th,e Zeru Only

21.45 Per 5m! Amp THIRD SAME AS IN ITEM5 ml vial/Amp

Page 15 of 34

Firm Name

1436


MaanPharmaceuticalsLtd

13.00 Per5 ml ViaUAmp

l Vial

15.3O Per5 ml ViaUAmp

Rupees Twenty One AND Paise Four Five Onlfo

Employees' State fnsura nce Corporation

Rate Schedule of Running Rate Contract No. U-25/121142C-L46C|zOLg-Med v FOR RC 146C

Valid from Thurcday, October 14th 2021 to Tuesday, October 31"t 2023


Firm Name Firm Rab/unit Packing

Preference De*ription of stores acepted

L440 Feracrylum Gel -

Each tube to contain: Feracrylum !o/o wlw15 gm Tube

Themis MedicarcLimited

Glaxo SmithklinePharmaceuticalsLtd


40.22Per10 9m Phial

1.49 Perl Tab/Cap

38.49 Per

15 gm Tube159mTube FIRST

Rupees Thifi Eight AND Pai* Four Nine Only

SEPGARD GEtSAME AS IN ITEM

NEOSPORIN ANTIBIOTICPOWDER

SAME AS IN ITEM

AVOSTERDE

SAME AS IN ITEM

10 gmPlasticBottle

FIRST

Rupees ForU AND Paise Two Two Only

7577 Dutasteride Tab/Cap-

Each Tab/Cap to contain: Dutasteride 0.5 mg

1 Tab/Cap

Cipla Limited

10 Caps FIRST

Rupees One AND Pai* Four lline Only

4.L4Per lOCaps SECOND DUPROST


Rupees Four AND Paise One Four Only

t44t Zinc Bacitracin + Polymp<in B Sulphate + Neomycin

Sulphate Powder-

Each Phial to contain: Zinc Bacitracin 400U,

Polymyxin B Sulphate 5000U, Neomycin Sulphate

3400u

10 gm Phial

Page 16 of 34 f*'?



Prefercnce De*ription of stores ac@pted

t579 Mix Lactobacilli Vaginal Tab/Cap-

Each Vaginal Tab/Cap to contain: Mix Lactobacilli

(L. Brevis,L.Salivarious And L.Plantarum ) 10E9

1 Tab/Cap

Rupees Sixty AND Paise Seven Zerc Only

t612 Sertaconazole Cream-

Each Tube to contain: Setaconazole Nitrate 2olo

Cream

10 gm Tube

BiodealPharmaceuticalsPrrt. ttd.


60.70 Perl Tab/Cap

15,77 ?et10 gm Tube


logm Tube FIRST SAME AS IN ITEM

10gm Tube FIRST KIoryl-SSAME AS IN ITEM

Rupees Five AND Paise Two Five Only.

Rupees Fifteen AilD Paise Seven *ven Only

t6t7 Clobetasol+Salicylic Acld Oint-

Each Tube to contain: Clobetasol Propionate 0,05o/o

w/w, Salicylic Acid 60lo w/w.

10 gm Tube

1633 Methylocobalamin Inj-Each ml to contain: Methylocobalamin 500 mcg

I ml Amp

1mI Amp FIRST SAME AS IN ITEM

Employ@s' State Insurance Corporation

Rate Schedule of Running Rate Contract No, U-25/12l142C-L46C|2OL9-Med V FOR RC 146C

Valid from Thursday, October 14fi' 2021 to Tuesday, October 31't 2023


8 TabsBottle

Unimarck Pharma(r) rtd

18.52 Per10 gm Tube

Rupees Eightecn AnlD Paise Five Two Only

5.25 Per1 ml Amp

Page 17 of 34

Em ployees' State fnsu ra ne Corporation

Rate schedule of Running Rate contract No. u-25/r2l142c-t46clzol9-Med v FoR Rc 146c

Valid from Thursday, October L+th 2O2t to Tuesday, October 3l* 2O2B

Item No Description Packing


FirmPacking

Prefercnce Description of stores ac@phd

Dexchlorpheniramine SR Tab/Cap-

Each SR Tab/Cap to contain: Dexchlorpheniramine

6mg

1 Tab/Cap


AristoPharmaceuticalsPvt, Ltd.

Psychotropics Indaa

Limited


2.38 Per 10 Tabsra!t

FIRST DEXODIL SRINSAM EAS1 pCa

Rupees Two AND Paise Thrce Eight Onlyo

ITEM

2,64 5 Tabs FI FEXOFEN MGl Tab/Cap SAME rTEM

Rupees

0.54 Per

10 Tabs SECOND

Paise Thrce Zero

0Ta RDIL 10SAME AS IN ITEMl Tab/Cap

Rupees Nil AND Pai* Five Four Only

1686 Fexofenadine Tab/Cap-

Each Tab/Cap to contain: Fexofenadine 180mg

t687

Page 18 of 34

1685

l Tab/Cap

Loratidine Tab/Cap-

Each Tab/Cap to contain: Loratidine 10mg

l Tab/Cap


Rate schedule of Running Rate contract No. u-25l12l142c-t46cl2olg-Med v FoR Rc 146cValid from Thursday, October 14th 2021 to Tuesday, October 31't 2023

ftem lYo Packing


Preference De$ription of stores acepted

Terbinafine Ointment/ Cream -

Each tube to contain: Terbinafine Hcl. 1%10 gm Tube

HabPharmaceuticals &Research LU


9,80 Per10 gm Tube

49.00 Per15 gm Tube

logm Tube FIRST

15ml Phial FIRST

LAMIFILSAME AS IN ITEM

ACNESIGN .C

SAME AS IN ITEM

SERTAVIV LSAME AS IN ITEM

Rupees Nine AilD Paise Eight Zero Only


WallacePharmaceuticalsPvt. Ltd.

Ruwes Forty iline Only

49,44Per 159m Tube SECOND SAME AS IN ITEM15 gm Tube

Rupees Fofi Nine AND Paise Four Four Only

53.00 Per 159m Tube THIRD ADAPLE-C GEL15 gm Tube SAME AS IN ITEM

Rupees Fifty Thte Only

tTtt 15 ml phial

67.48 Per15 ml phial

Rupees SixU Seven AND Pai* Four Eight Only

L704 15 gm Tube

Page 19 of 34

Decrinlinn

1703

Acne Gel- Each Tube to contain: Adapalene 0.1olo

IPIBP/USP etc w/w (As Microsheres) ClindamycinPhosphate IPlBP/USP etc Equivalent To ClindamycinI.0o/o w/w in an Aqueous Gel Base -Q.S.

159m Tube FIRST

Sertaconazole Nitrate Lotion-

Each Phial to contain: Sertaconazole Nitrate 2olo

w/vPropylene Glycol Base Qs

Vivimed Labs Ltd,

,4-*r'.,*t-

Employes' State fnsurance Corporation

Rate Schedule of Running Rate Contract No. U-25/121142C-l46Cl2OLg-Med V FOR RC 146C

Valid from Thursday, October L4t' 2O2L to Tuesday, October 31't 2023



I FirmI Packinq

Preference De*ription of stores a@phd

Benzoyl Peroxide Gel-

Each pack to contain: Benzoyl Peroxide 2.5olo

20 gm Pack


WallacePharmaceuticalsPvt. ttd.

Midas CarcPharmaceuticalsPr^. Ltd.

18.00 Per

20 gm Pack2ogm Pack FIRST SAME AS tN ITEM

Rupes Twenty Four AND Paise fluo Zeto Only

1718 Adapelene Gel-

Each Tube to contain: Adapelene 0.lpercent15 gm Tube

29,23 Per 15gm Tube FIRST SAME AS IN ITEM

Rupees Tfuenty lVine AlyD Paise Two Thr@ Only

Isopropyl Alcohol Spray-

Each pack to contain: Isopropyl Alcohol-Sso/o w/w,Purifi ed Water-10o/o w lw, Propellant Hydrocarbon-

35o/o w/w

200 gm Pack

Rupees Eighten Only,,

20gmTube SECOND PERSOL AC 2,5SAME AS IN ITEM

MIDAS CARE ISOPROPANOTSPRAY

SAME AS IN ITEM

150.21 Per200 gm Pack

20OgmPack

FIRST

Rupees One Hundtd Fifty AND Pai* Two One Only

Page 20 of 34

ftem No

t712

24.20 Per20 gm Pack


t723


Rate Schedule of Running Rate Contract No. U-25/12l142C-L46C|2OLg-Med V FOR RC 146C

Valid from Thurcday, October 14th 2021 to Tuesday, October 31't 2023



FirmPacking

Prefercnce Description of stores accephd

t793 Calcium Tab/Cap-

Each Tab/Gp to contain: Calcium Citrate Malate

Equivalent to Elemental Calcium 250m9, Calcitriol

0.25 mcg,Vitamin K2-7 50mcg.

Vivimed Labs Ltd.

PulsePharmaceutical hrtLtd

2.99 Per1 Tab/Cap

Rupees fwo AND Paise Nine Nine Only

4.23 Per 10 Tabs SECOND

l Tab/Cap

MORECAL K27SAME AS IN ITEM

XTRACAL K2

SAME AS IN ITEM

Rupe* Four AND Paise Two Thrce Only

1887 Sildenafil Tab/Cap -

Each Tab/Cap to contain: Sildenafil 50mg

l Tab/Cap

Zim LaboratoriesLimited


1.52 Perl Tab/Cap

4 Tabs FIRST

Ruwes One AND Pai* Five TWo Only

5.25 Per 4 Tabs SECOND VEGA-SO


Rupees Five AND Paise Two Five Only

Page 21 of 34

1 Tab/Cap

10 Tabs FIRST

ZIMAGRA 50SAME AS IN ITEM

f^:


Rate Schedule of Running Rate Contract No. U-25l121142C-L46C|zOL9-Med V FOR RC 146C

Valid from Thurcday, October t4d'2O2L to Tuesday, October 31st 2023



FirmPacking

1940 50 ml Bottle

Rupees Thitty Six AND Paise Six Thrce Only

FIRST KETOPIL LOTIONSAME AS tN ITEM

SECOND FUNGICYTE

SAME AS IN ITEM

5OmlBottle



THIRD SAME AS IN ITEM

Rupees Fifry Four Only

Clotrimazole Dusting Powder-

Each pack to contain: Clotrimazole Dusting Powder 1

75 gm Pack




Rupees Forty Six AIVD Paise Five Zeto Only


19.98 Per75 gm Pack

75gm Pack FIRST SAME AS IN ITEM

Rupees Nineteen AND Paise Nine Eight Only

21.69 Per 75gm Pack SECOND CLORIMAZ75 gm Pack SAME AS IN ITEM

Rupees Twenty One AND Paise Six Nine Only

42.51 Per 75gm Pack THIRD SURFAZ POWDER75 gm Pack SAME AS IN ITEM

Rupees Forty Two AND Paise Five One Onlyo

Page ZZ of 34

, Prefetence

I

DescriOtion of storcs accepEd

Ketoconazole Lotion-

Each Bott to contain: Ketocon azole 2o/o wlv

Psychotropics India 36.63 PerLimited 50 ml Bott

L942

Franco-IndianRemedies hrt Ltd

/*^r

Employees' State Insurance Corporation

Rate Schedule of Running Rate Contract No, U-25lLzlL42C-l46Clzolg-Med v FOR RC 145C

Valid from Thursday, October 1+h 2021 to Tuesday, October 31't 2023


Firm Rate/unit Packing

Prefercnce De*ription of stores ac@phd

Luliconazole Cream-

Each Tube to contain: Luliconazole 1olo

10 gm Tube

Zenith Drugs Pvt.Ltd.

Chery! laboratoriesPrivate Limited

127.00 Per60 ml Bott

1L.77 Per10 gm Tube

Rupees Eleven AND Paise Seven Seven Only

34.34 Per 109m Tube SECOND SAME AS IN ffEM10 gm Tube

Rupees Thitty Four AIYD Paise lhrce Four Only

34.95 Per l0gmTube THIRD TUCOZCREAM

10 gm Tube SAME AS IN ITEM

Rupees Thirty Four AND Paise Nine Five Only

t946 Minoxidil Lotion-

Each Bott to contain: Minoxidil 2olo

60 ml Bottle

Rupees One Hundrcd Twenty Seven Only

L947 l"linoxidil Lotion-

Each Bott to contain: Minoxidil 5olo

60 ml Bottle

129.77 Per60 m! Bott

50mlBottle

50mlBottle


FIRST SAME AS IN ITEMCheryl LaboratoriesPrivate Limited

Rupees One Hundred Twenty lVine AND Palse Seven Seven Only

Page 23 of 34

Firm Name

t944

BiodealPharmaceuticalsPvt. ttd.

Ajanta PharmaLimited

logm Tube FIRST SAME AS IN ITEM

t:



1956 Paraffin Gauze-

Each Piece to contain: Paraffin Guaze 10cm X 10cm

10 Pieces



R

3.29 Perl Tab/Cap

Pouch of FIRST BIONET10 Pieces SAME AS IN ITEM

Nine AND Paise Three Ze,o

MIKRONUTRIENT C PIUSCAPSULE

SAME AS IN ITEMR Three AND Paise Two Nine

7.19 Perl Tab/Cap

10 Caps FIRST ASTYMIN M FORTE

SAME AS IN ITEM

Rupees Seven AND Paise One Nine Only

19s8 Multi Vitamin Tab/Cap-

Each Hard Gelatin Tab/Cap to contaln: Ferrous

Fumarate I.P Eqv. to Elemental Iron 30 mg, Folic Acid

I.P 250 mcA, Zinc Sulphate Monohydrate B.P. Eqv. toZinc 20 mg, Thiamine l4ononitrate (Vit. 81) LP. 1.2

mg, Riboflavin (Vit. 82) I.P. 1.2 mg, NiacinamideI.P.10 mg, Pyridoxine Hydrochloride (Vit. 86) I.P. 1

mg, Cyanocobalamin (Vit. 812) I.P. 2.5 mcg

Ascorbic Acid Coated (Vit. C) I.P. 40 mcq

1 Tab/Cap

1959 Multi Vitamin With Amino Acid Tab/Cap-

Each Tab/Cap to contain: L-Arginine Hydrochloride

USP 13.28m9, L-Histidine Hydrochloride H20 BP

3.7lmg, L-Isoleucine USP 5.9m9, L-Leucine USP

18.3m9, L-Lysine Hydrochoride USP 25.0m9, DL-

Methionine BP 18.4m9, L-Phenylalanine USP 5mg, L-

Threonine USP 4.2m9, L-Tryptophan USP 5mg, L-

Valine USP 6.7m9, s-Hydroxy Anthranilic Acid HCL

0.2m9, Cholecalciferol IP 200 IU, Nicotinamide IP

25m9, Pyridoxine Hydrochloride IP 1.5m9,

Methylcobalamin 500mcg, Biotin USP 30mcA, Folic

Acid IP 0.75m9, Copper Sulphate BP 4mg, Ferrous

Sulphate IP 20.5m9, Magnesium Sulphate IP7 .43m9, f4anganese Sulphate BP 1.4m9, Potassium

Iodide IP 0.1m9, Sodium Selenite BP 10.omcA, Zinc

Sulphate IP 15mq, Chromium Polynicotinate 200mcg

l rab/Gp

Page 24 of 14

?

Employ@s' State Insurance Corporation

Rate Schedule of Running Rate Contract No. U-251 L2l 142C-l46Cl2OL9-Med V FOR RC 146C

Valid from Thurcday, October 14th 2021 to Tuesday, October 31st 2023

Firm Name Prefercnce De*ription of storcs ac@pted

Tablets (India)Limited

59.30 Per10 Pieces

10 Caps FIRST

tr

Employes' State fnsuran@ Corporation

Rate Schedule of Running Rate Contract No. U-25/12l142C-L46C|2OL9-Med V FOR RC 146C

Valid from Thursday, October 14th 2O2l to Tuesday, October 31"t 2023


Firm Rate/unit Packinq

Description of stores ac@pted

t962 Ferrous Ascorbate With Aminoacids & Zinc Tab/Cap-Each film coated Tab/Cap to contain:FerrousAscorbate equivalent to elemental Iron 100m9,It4ethylcobalamin 1000mca, Folic Acid 1.5m9, L -

Histidine Hcl H2O 4mg, L - Lysine Hcl 25m9, Glycine

10m9, Pyridoxine Hcl 1.5mq, Zinc Sulphate 50mq

l TablCap

Lupin Limited

EmcurePharmaceuticalsLtd

Themis MedicareLimited

8.O4 Perl Tab/Cap

10 Tabs FIRST

10ml Vial FIRST

1X 10 mlVial

Rupees One Thousnd Thte Hundrcd Eighty Nine AND Pai* Nine Zerc Only

1389.90 Per10 ml Vial

1430.00 Per10 ml Via!

Rupees Eight AND Paise Zero Four Only

REVOFER

Manufacturcd Byr-M/s Vifor (tnternational)Inc, SwiEerlandSAME AS IN ITEM

SECOND SAME AS IN ITEM

Rupees One mousand Four Hundred Thhty Only

20gm Tube FIRST

2049 Ferric Carboxy Maltose Eqv. To Elemental Iron 50 mgInj-Each ml to contain:

Ferric Carboxy Mal . to Elemental Iron 50mg

10 ml Vial

2103 Feracrylum With Centbucridine Hydrochloride Gel-

Each Tube to contain: Feracrylum 3o/o wlw,Centbucridine 0.5olo w/w (As Centbucridine Hcl)

Water Miscible Base Q.S.

Page 25 of 34

Firm Name Prefercnce


59.90 Per20 9m Tube

ASTYFER XTSAME AS IN ITEM

SEPGARD AR GELSAME AS IN ITEM

Rupees Fifty Nine AilD Paise Nine Zeru Onlya

20 gm Tube

P

Employees' State Insurance Corpration

Rate Schedule of Running Rate Contract No. U-25l121142C-t46Cl2OL9-Med V FOR RC 146C

Valid from Thursday, October 14th 2021 to Tuesday, October 31"t 2023



Prefetence

2704 Posaconazole Soln-

Each Phial to contain :

Posaconazole Oral Soln 4Omg/ml

105 ml Bottle

Fulford (India) 10593.33 Per 105m1 FIRST NOXAFITLimited (A 105 ml Bott Bottle Manufactured by:-Subsidiary Of Cenexi HSC FranceMerck Sharp & SAME AS IN ITEMDohme Corp, Usa)

Rupees Ten Thousand Five Hundrcd Ninety Thte AND Pai* Three Thte Only

Each Film Coated Tab/Cap to contain:Calclum Aspartate 500m9, Calcium Orotate 500m9,Calcitirol 0.25mca, Zinc(As Zinc SulphateMonohydrtae IP) 7.5m9, Magnesium Hydroxide IP

50m9, Hydroxocobalamin IP 100mcg, Folic Acid IP1.5m9, Excepients q.S.

1 Tab/Cap


Indoco RemediesLtd

8.87 Perl Tab/Cap

9.75 Perl Tab/Cap

10 Tab FIRST

EZORB FORTE

SAME AS IN ITEM

Rupecs Eight AND Paise Eight *ven Only

Rupees Nine AND Paise Seven Five Only

Each Tab/Cap to contain:Atorvastatin Calcium IP Equivalent to Atorvastatin

10m9, Methylcobalamin 500 mcg, Folic Acid IP Smg

, Pyridoxine Hcl IP 10mq

1 Tab/Cap

De*ipfion of stores acepbd

2tt2

lOTAbs FIRST

ATHEROCHEK-10SAME AS IN ITEM

2tt3

Page 26 of 34 P

Employes' Stale fnsurance Corporation

Rate Schedule of Running Rate Contract No. U-25/12l142C-l46Cl2Ol9-Med V FOR RC 146C

Valid from Thursday, October !4s'2021to Tuesday, October 31"t 2023



Preference

2tt5 Hematinic With Amino Acids,Vitamins And Zinc

Syrup:

Each 10 ml to contain :

Ferrous Glycine Sulphate 216.5 mg, L-HistidineHydrochloride H2o BP 4 mg, L- Lysine HydrochlorideUSP 25 mg , Pyridoxine Hydrochloride IP 1.5 mg,

Nicotinamide IP 25 mg, Folic Acid IP 0,5 mg,Cyanocobalamin IP 2.5 mcq, Zinc Ascorbate 50mq



Virchow BiotechA^. Ltd

69.50 Per20O ml Bott

43.00 Per15 gm Tube

FIRST

15gm Tube FIRST

ASWFER Z LTQUTD

SAME AS IN ITEM

CATFTAVONE

SAME AS IN ITEM

IonsilSAME AS IN ITEM

Rupees Sixty Nine AND Paise Five Zero Only

8.69 Perl Tab/Cap

30 Tabs FIRST

Rupees Eight AND Paise Six Nine Only

2246 Silver Nitrate Gel-

Each Tube to contain: Silver Nitrate Gel 0.2olo w/w15 gm Tube

Rupees Forty Thrce Only

2tL6 Iprifl avone,Calcium,Vit D3 Tab/Cap:

Each Film Coated Tab/Cap to contain: Calcium

Carbonate 1.0 gm From Organic Source(OysterShell) Equivalent to Elemental Calcium 400 mg,

Ipriflavone 300 mg, Cholecalciferol IP 200 IU

I Tab/Cap

Page 27 ol a4

Firm Name De*ription of stores ac@phd

200 ml Bott

20OmlBottle

f:

Em ployees' Sbte fnsurance Corporation

Rate Schedule of Running Rate Contract No. U-25l12l142C-146C12O19-Med V FOR RC 146C

Valid from Thurcday, October 14th 2021 to Tuesday, October 31st 2023

fhm No Drug Description Packinq

Firm NamePacking

Preference Description of stores acepted

Papain - Urea Debriding Oinment

Rupees One Hundrcd Twenty Two AND Paise Two Zeto Only

2402 lulethylcobalamin Tab/Cap :

Each Tab/Cap to contain: Methylcobalamin 1500 mcA

1 Tab/Cap

Virchow BiotechPvt. Ltd

PulsePharmaceutical hrtLtd

MaanPharmaceuticalsLtd


Vivimed Labs Ltd,

l22,2OPer15 gm Tube

0.94 Perl Tab/Cap

L94.26 Per100 gm Bott

159m Tube FIRST

15 Tabs FIRST

Rupees Nil AND Paise Nine Four Only

L.44Per 10 Tabs SECOND MANIMl Tab/Cap SAME AS IN ITEM

Rupees One AND Paise Four Four Only

1.46 Per 10 Tabs THIRD SAME AS IN ITEMl Tab/Cap

R One AND Paise Four Six

DEBRIDACE(EACH GM OF OINTMENT

CONTAINS: PAPAIN IP > 521700

UNITS UREA IP IOOMG)

SAME AS IN ITEM

MECONEURON OD

SAME AS IN ITEM

SERTAVW

SAME AS IN ITEM1009mBottle

FIRST

Rupees One Hundred Ninety Four AND Paise Two gix Only

100 gm Bottle2403 Sertaconazole Nitrate Powder-

Each Bott to contain :

Sertaconazole Nitrate 2% w/w ,Talc IP Base Q.S.

Page 28 of 34

Firm Rab/unit

2247 15 gm Tube

ftem No Drug Descrtpfion Packing


Description of stotes acep@d

2406 Fus;dic Acid Oint/Cream :

Each Tube to contain : Fusidic Acid 2o/o

15 gm Tube

SignaturePhytochemicalIndustries


WallacePharmaceuticalsPrrt. Ltd.


159m Tube FIRST MICOFTU N

SAME AS II{ ITEM

34.90 Per15 gm Tube


Rupees Thirty Four AND Pai* Nine Zero Only

44.10 Per 15gm Tube SECOND SAME AS IN ITEM15 gm Tube

Ruryes Forty Four AND Paise One Zerc Only

53.00 Per 15gm Tube THIRD FUSIWALCREAM15 gm Tube SAME AS IN ITEM

Rupees Fifty Three Only

2408 Fluocinolone + Neomycin + Miconazole Oint/Cream-Each Tube to contain: Fluocinolone Acetonide0.025o/o, Neomycin Sulphate 0.5%o, Miconazole

Nitrate 2.00/o

Rupees Twenty Six AND Pai* One Zerc Only

39.90 Per 159m Tube SECOND FTUCREME NM15 gm Tube SAME AS IN ITEM

Rupees Thirty Nine AIUD Pai* Nine Zeto Onlya

Em ployes' State fnsurance Corpration

Rate Schedule of Running Rate Contract No. U-25lL2ll42C-L46Cl2OL9-Med V FOR RC 146C

Valid from Thurcday, October L4th 2OZL to Tuesday, October 313t 2023

Firm Name Prcfercnce

ConceptPharmaceuticalsLtd.

26.10 Per15 gm Tub€

15 gm Tube

Page 29 of 34

Employees' State Insurance Corporation

Rate Schedule of Running Rate Contract No. U-25/121142C-L46C|zOLg-Med V FOR RC 146C

Valid from Thursday, October !4b 2O2L to Tuesday, October 31't 2023

ftem No Drug Descrtption Packing


Pteference De*ription of stores acepfud

2409


MacleodsPharmaceuticalsLimited


19.0O Per15 gm Tube


Rupe* Twenty Thte AND Paise Four Nine Only

Bal Pharma Limited 45.54 Per 15gm Tube THIRD KETOVATE159mTube SAMEASIN ITEM

Rupees Forty Flve AND Paise Five Four Only

24t7 Montelukast & Levocetrizine Kid Tab/Cap-Each Tab/Gp to contain: Montelukast 4mg &Levocetrizine 2.5m9

1 Tab/Cap

Cipla Limited 0.76 Perl Tab/Cap

Ruwes Nil AND Paise Seven Slx Only

lOTabs FIRST MONTAIR LC KID TABSAME AS IN ITEM

1,4O Per 10 Tabs SECOND MONTEMAC L KIDl Tab/Cap SAME AS IN ITEM

1.88 Per 10 Tabs THIRD PII.ZINE M KIDl Tab/Cap SAME AS IN ITEM

Rupees One AND Paie Eight Eight OnlyC

Ketoconazole Oint/Cream-

Each Tube to contain: Ketoconazole 2olo

15 gm Tube

SignaturcPhytochemicalIndustries

Rupees Nineten Only

l59m Tube SECOND SAME AS IN ITEM23.49 Per15 gm Tube

RuBes One AND Pai* Four Zero Only

Page 30 of 34 {2


PrefercnceFirmPa*ing

Firm Name Dexription of stotes acePhd

1157b Human Chorionic Gonadotropin Inj-Each Vial/Amp to contain : Human Chorionic

Gonadotropin 5000 IU

1 ml ViaUAmp

Vitamin E Tab/Cap-

Each Tab/Capule to contain:

Vit. E (Alpha Tocopherol Acetate) 400m9

l Tab/Cap

1.40 Perr Tab/Cap

l vial

10 Caps FIRST

lOTabs FIRST

VITAEOL 4OO

SAME AS tN TTEM

Procter & GambleHealth Limited(Formerely KnownAs Merck Limited)

Rupees One AND Pai* Four Zeto OnlY

2.34 Per 10 CaPs SECOND EVION 400

l Tab/Cap SAME AS tN ITEM

RupeesTwo AND Paise Thrce Four OnlY

1426b 1 Tab/Cap

Rupees Four AND Paise Th,ee Seven Onlya

Page 31 of 34


Rate Schedule of Running Rate Contract No. U-25l12l142C-L46C|20,9-Med V FOR RC 145C

Valid from Thursday, october 14th 2021 to Tuesday, October 315t 2023

Firm RaE,/unit

160.00 Per1mlViaUAmp

Ruryes One Hund,Ed SiW OnlY

1302c

Bharat Serums And

Vaccines Limited

Jyoti CapsulationsPrrt. Ltd

FIRST HUCOG .sOOOHP

SAME AS IN ITEM

[,

Bal Pharma Limited 4.37 Perl Tab/Cap

EBAL 20SAME AS IN TTEM

tl ' ,l/

-

I

VL

Ebastine Tab/Cap-

Each Tab/Cap to contain: Ebastine 20mg

3I

FirmPacking

Firm Rate/unit

Dexription of stores arcPEd

408a Efihropoietin IniEach PFS to contain:

Recombinant Human Efihropoietin 2000 Units

1 PFS

IntasPharmaceuticalsLtd

GennovaBiopharmaceuticalsLtd.

mzer ProductIndia Private Ltd

151.00 Per1 PFS

1 mI PFS FIRST

Ruryes Ninety Nine AND Pai* Nine Nine Only

SECOilD VINTOR 2OOO IUSAME AS IN TTEM

WEPOX 3000SAME AS IN ITEM

1 PFS

R One Hundrcd Twen Thrce On

O.3mI PFS FIRST

Rupee.c One Hundrd FifrY One OnU

Human Growth Hormone-

Each Cartridge to contain:

Somatropin 16 IU (R-DNA Origin)/ Somatropin

5.3m9 (R-DNA Origin)

1 Cartridge

4240.00 Per l Cartridge FIRST

1 Cartridge

Rupees Four fhousnd TWo Hundtd Fofi Only

GENOTROPIN 16IU(5.3mg)/mlManufactured by:-M/S Pfizer ManufacturingBelgium NV, Rijksweg 12

Puurc (Belgium)SAME AS IN ITEM

,.2

1 PFSEfihropoietin IniEach PFS to contain:

Recombinant Human Efihropoietin 3000 Units


Rate Schedufe of Running Rate Contract No. U-25l121142C'L46C|2OLg-Med V FOR RC 146C

Valid from Thursday, October 14dr 2021 to Tuesday, October 31"t 2023

Firm Name Preference

PackincDrug Descriptionf ttem no I

99.99 PerT PFS

123.00 Per1 PFS

RENOCEL 2OOO IUSAME AS IN ITEM

E

L u*

Wockhardt Ltd.

509a

408d

Page 32 of 34



Description of storcs acePhd

546a Paper Adhesive Tape-

Paper Adhesive Tape Hypoallergenic With Acrylate

Adhesive 2.5cmx9.14m

1 Roll

Rupees Seventeen AND Paise Three One Only

546b 1 Roll

Essity India PrivateLimited (FormerlyBSN MedicalPrivate Limited)

Goldwin MedicarcLtd,

Essity India PrivateLimited (FormerlyBSN MedicalPrivate Limited)

6 Rolls Box SECOND

Leukopor 2.5cmx 9.14mManufactured by:-Chensin Packaging IndustryCo., LTD. (ROC), TaiwanSAME AS IN ITEM

CLINIPORESAME AS IN ITEM

Leukopor5cm X9.14mManufactured by:-Chensin Packaging IndustryCo., LTD. Repoublic of China(ROC), TaiwanSAME AS IN ITEM

34.61 Per1 Roll

33.20 Perl Roll

1 Roll FIRST

Rupes Thifi Thte AND Paise TWo Zerc Only

Rupees Thifi Four AND Pal* Six One Only.-

Page 33 of 34


Rate Schedule of Running Rate Contract No. U-25/12l142C-l46Cl2OLg-Med V FOR RC 146C

Valid from Thursday, October 14o' 2021 to Tuesday, October 31"t 2023

Firm Name Prcfercnce

Paper Adhesive Tape-

Paper Adhesive Tape Hypoallergenic With Acrylate

Adhesive 5cmx9.14m

17.31 Per1 Roll

t2 RollsBox

FIRST

t tu

Employees' State fnsurance CorPoration

Rate schedule of Running Rate contract No. u-25/12l142C-l46Cl2OL9-Med V FOR RC 146C

Valid from Thursday, October 14th 2021 to Tuesday, october 315t 2023

Packingfbm No Drug Description

Firm llame Firm RaE/unit Packing

Pteference Dexription of stor* acepted

558b Finasteride Tab/Cap-

Each Tab/Cap to contain: Finasteride 5mg

l Tab/Cap

Hab 3.56 Per 10 Tabs FIRST PROSTRIDE

iiirmaceuticars a i'rfq€F s =F'- F-+ -r* - =

*qtryffi 4 g.ErqL*t

ResearchLtd t^# e fti}*",oe;ffi-* t Li

I

202L-2023

Page 34 of 34

t-r

Ia-

iIt-!

Documents

FOR SUPPLY OF DRUGS DRESSINGS